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Abstract 
The MGIT 960 a high capacity, automated, non-invasive liquid culture system 
was proposed as an alternative to the BACTEC 460, a semi-automated, radiometric 
liquid culture system, for the growth of mycobacteria from bovine lymph node (LN) 
tissues.  A limit of detection study for Mycobacterium bovis, spiked into negative LN 
tissue, showed that both liquid culture systems supported growth down to a 
concentration of 2.5 x 10
2
 cfu/ml.   
A total of 867 routine LN tissues mainly from bovines but including some 
badger, deer and sheep tissues, were cultured on both liquid culture systems and on 
solid culture systems (Stonebrinks and LJP).  For MTBC (Mycobacterium 
tuberculosis complex) isolates 92%, 93.2% and 73.9% grew on BACTEC 460, MGIT 
960 and solid culture systems respectively.  MGIT 960 detected growth of MTBC 
isolates slightly faster than the BACTEC 460 system (14.6 days compared to 15.2 
days respectively).  For Rhodococcus equi isolates 42%, 96.6% and 42% grew on 
BACTEC 460, MGIT 960 and solid culture systems respectively.  For atypical 
mycobacteria isolates 89.5%, 43.4% and 10.5% grew on BACTEC 460, MGIT 960 
and solid culture systems respectively.  For Mycobacterium avium isolates 33.3%, 
100% and 33.3% grew on BACTEC 460, MGIT 960 and Solid culture systems 
respectively.  Contamination rate was 3.1%, 8.2% and 10.9% for BACTEC 460, 
MGIT 960 and solid culture systems respectively.  For growth of MTBC, M. avium 
and R. equi isolates MGIT 960 system gave a similar or better detection rate 
compared to BACTEC 460 but gave a poorer isolation rate for the growth of atypical 
mycobacteria.  Even with the higher contamination rate the MGIT 960 system was a 
suitable alternative to the BACTEC 460 system. 
A decontamination study, comparing 5% oxalic acid and 0.75% CPC 
(cetylpyridinium chloride), was carried out to determine if CPC could be used with 
the MGIT 960 system.  CPC is not a suitable decontamination chemical for use with 
MGIT 960 system since only 47.4% of MTBC isolates were identified with CPC 
compared to 100% with oxalic acid decontamination. 
A study to compare five extraction methods to detect mycobacterial DNA 
directly from decontaminated LN tissue to determine which if any could be used, with 
culture, for rapid diagnosis of high priority samples such as singleton reactors and 
samples with potential human involvement.  This study showed that heat lysis and the 
Roche High Pure Template Preparation kit were not specific or sensitive enough for 
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this purpose.  Immunomagnetic separation (IMS) gave a limit of detection result for 
M. bovis of 2.3 x 10
2 
cfu/ml when spiked into PBS but this increased to 2.3 x 10
3 
cfu/ml when spiked into negative LN tissue.  IMS is not sensitive enough for the 
detection of mycobacterial DNA directly from decontaminated LN tissue.   
GenoType Mycobacteria Direct kit, with the addition of an overnight 
Proteinase K digestion, correctly identified 63.3% of the decontaminated LN tissues 
with 16.7% false negatives, the remainder of the samples failed.  A persistent problem 
with the test was the failure of the positive control sample, supplied with the kit, to be 
correctly identified. 
Sequence Capture PCR, a known method for the detection of mycobacterial 
DNA in LN tissue, correctly identified 73.3% of the samples and the remaining 26.7% 
samples gave false negative results. 
Both the GenoType Mycobacteria Direct kit and Sequence Capture PCR could 
be suitable for the direct detection of mycobacterial DNA from decontaminated LN 
tissues with further work required to reduce the number sample failures and improve 
the sensitivity of both tests.   
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1.1 Introduction 
Tuberculosis (TB) has been an important disease of man and animals since 
antiquity.  It has been detected using molecular biology methods, from the bones of 
1000-year-old mummified remains in South America and from 3000-year-old remains 
in Egypt. The oldest isolated tuberculosis sequence has been identified from 17,000-
year-old fossilized bison remains (Zink et al., 2002; Chadwick, 1982).   
The causative agent of tuberculosis was isolated in 1882 by Robert Koch when 
he identified Mycobacterium tuberculosis in infected tissue and announced his 
discovery to the Physiological Society of Berlin (Chadwick, 1982).  He also 
developed staining techniques for M. tuberculosis, a culture medium that would grow 
the organism and proved that the bacterium he identified was the causative agent of 
TB (Chadwick, 1982; Collins, 1997; Schluger, 2005).  
The World Health Organisation (WHO) estimates that a third of the world‟s 
population is infected with TB.  Active TB develops in 8 - 10 million people annually 
and causes an estimated 3 million deaths.  Even with this high infection rate only 10% 
of the non-immunocompromised individuals infected will ever become symptomatic.  
People that have a dual infection with TB and Human Immunodeficiency Virus (HIV) 
have a 50% chance of developing the disease and there is evidence to suggest that 
having a latent TB infection may accelerate the progression of HIV/AIDS (Collins et 
al., 1997; Schluger, 2005; Mathema et al., 2006). 
In Ireland the current TB notification rate, as of 2009, stands at 10.9 per 
100,000 of population (472 new TB cases).  This has dropped from 230 cases per 
100,000 of population in 1952, when the first national survey of TB in Ireland took 
place.  This drop was due to the development of a suitable treatment protocol and the 
success of the bovine TB eradication scheme.  The notification rate for TB continued 
to drop annually until 2001 after which it stabilised, with minor fluctuations in the 
annual figures (National TB Advisory Committee, 2010; ECDC, 2011).     
 
1.1.1 TB Infection 
The symptoms of a TB infection are non-specific and patients typically present 
with coughing, expectoration (coughing up sputum), haemoptysis (coughing up 
blood), chest pain and general symptoms, such as fever, sweating and weight loss, that 
have continued for several weeks.  The organ most frequently infected by TB is the 
lung but the disease often occurs in the lymph nodes, kidneys, central nervous system, 
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intestine, bones and reproductive system with no part of the body exempt from 
infection (González-Martín, 2010).   
TB is most commonly spread by inhalation of small droplets that contain a few 
bacilli, from the lungs of a TB patient.  The bacilli enter the lungs and are 
phagocytosed by the alveolar macrophages.  This starts the host cellular immune 
response, involving large amounts of cytokines and chemokines, which limit the 
infection to the site of invasion and the local draining lymph nodes.  This is known as 
a “Ghon Complex” (Collins et al., 1997; Mathema et al., 2006).   
The macrophages also activate a cell-mediated immune response, which takes 
about 10 days to develop.  This response leads to the formation of a granuloma, which 
halts and contains the infection for approximately 95% of infected individuals.  Most 
of the bacilli are eliminated but some remain in a dormant state within the granuloma 
and this is a latent TB infection.  In the remaining 5% of individuals the infection is 
not contained and the bacilli continue to replicate leading to the development of 
disease symptoms and associated pathology, including cavitation and tissue necrosis 
(Collins et al., 1997; Mathema et al., 2006).      
In a further 5% of individuals, within whom the TB infection was contained 
by the granuloma formation, the disease becomes reactivated and symptoms develop 
some time after the initial infection.  It is not fully understood why this happens but it 
may possibly be due to a weakening in the patient‟s immune system for several 
reasons such as age, uncontrolled diabetes mellitus or chemotherapy (Collins et al., 
1997; Mathema et al., 2006).  
 
1.1.2 TB Treatment 
Once the causative agent of TB had been discovered attempts were made to 
find a successful treatment and a vaccine against the disease.  Koch made an error in 
1890 when he declared that he had discovered a compound that would cure the 
disease and provide protection against it.  What he had identified was a glycerine 
extract from the mycobacterium, which provides no protection against the disease, 
and does not improve symptoms (Thoen and Steele, 1995).  However, it did lead to 
the development of a useful diagnostic tool for TB, the tuberculin skin test 
(Chadwick, 1982). 
For many years after the isolation of mycobacteria, care for TB infection 
remained palliative, providing good nutrition, fresh-air, exercise and rest, with 
20 
 
patients being isolated in hospitals or sanatoria away from the community to limit the 
spread of the disease. With the discovery of effective anti-tuberculosis drugs, 
beginning in the 1940s with streptomycin and para-aminosalicylic acid (PAS), 
treatment of the infection became possible (Chadwick, 1982; Palomino et al., 2007).  
 Early drug trials indicated that a combination of both streptomycin and PAS 
was more effective against TB than either drug alone, and so long courses of multi-
drug anti-tuberculosis treatment began (Palomino et al., 2007).  Continued research 
lead to the discovery of more anti-tuberculosis drugs, which improved the treatment 
efficacy and shorted its duration, these included isoniazid in 1952, ethambutol, as a 
replacement for PAS, in 1960, rifampicin in the 1970s and pyrazinamide in 1980 
(Palomino et al., 2007).     
The aim of anti-tuberculosis treatment is to rapidly kill metabolically active 
bacilli within the lung tissue, to prevent further transmission of the infection in 
sputum, and to achieve complete sterilization and elimination of any semi-dormant 
TB bacilli within closed lesions in the lungs or in host tissues throughout the body.   
The current TB treatment regime, recommended by the WHO, is a minimum of six 
months long and includes an intensive two month, daily treatment with a combination 
of isoniazid, ethambutol, rifampicin and pyrazinamide, followed by a four month, 
daily treatment with isoniazid and rifampicin. These four drugs, along with 
streptomycin, are the first-line TB drugs (Palomino et al., 2007; WHO, 2009).   
A human infection with Mycobacterium bovis can be cured with the 
recommended TB treatment regime since wild-type M. bovis is sensitive to most anti-
TB drugs, except pyrazinamide to which it has a natural resistance.  Partly for this 
reason, but also due to limited laboratory resources, more efforts are not made in 
countries with a high TB burden to diagnose the type of TB infection (Michel et al., 
2010).  In animals, treatment for a TB infection depends on the specific reactions of 
individual species to the anti-TB drugs, the logistics and cost of administering 
multiple drugs over several months.  It has been carried out for some rare animal 
species in captivity but it would not be viable for herd animals.  In the UK, drug 
therapy for bovine TB is illegal since its use has been shown to compromise the 
tuberculin skin test (Michel et al., 2010; Dean et al., 2008). 
Drug resistance develops as a result of TB treatment failure due to numerous 
reasons such as presence of cavitation, with TB positive sputum, or co-infection with 
HIV or non-adherence to the required treatment regime, either due to cost and 
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availability of the drugs, length of treatment or adverse drug reactions (Palomino et 
al., 2007; Cole and Riccardi, 2011; Ahmad and Mokaddas, 2009).  Where possible, 
drug susceptibility testing on TB isolates should be carried out and if resistant strains 
are identified the TB treatment regime can be modified.  First-line drugs can be 
replaced with second-line drugs such fluoroquinolones, aminoglycosides, ethionamide 
and D-cycloserine, however these are less effective, lengthen the treatment regime 
and cause more adverse drug reactions (Palomino et al., 2007; Cole and Riccardi, 
2011; González-Martín et al., 2010).   
Multidrug resistant TB (MDR-TB) refers to M. tuberculosis isolates that are 
resistant to both isoniazid and rifampicin.  Among the total worldwide TB cases an 
estimated 5.3% are MDR-TB.  This form of TB infection is problematic to treat and 
often leads to relapse and treatment failure (Cole and Riccardi, 2011).  It is also a risk 
factor for the emergence of XDR-TB (extensively-drug resistant TB) strains, which 
are MDR-TB strains that have acquired resistance to the second-line TB drugs, 
fluoroquinolones and aminoglycosides.  Over 50 countries have reported one or more 
incidence of a XDR-TB infection with up to 10% of all MDR-TB cases in former 
Soviet Union countries and 5.6% of MDR-TB cases in South Africa identified as 
XDR-TB.  XDR-TB strains are difficult to treat in developed countries and nearly 
untreatable in developing countries (Cole and Riccardi, 2011; Ahmad and Mokaddas, 
2009).   
The search for new drugs to treat TB continues and with the emergence of 
XDR-TB strains there is urgent requirement for new treatment regimes.  The 
difficulty is that any new TB drug needs to be effective not only against metabolically 
active bacilli but also against the latent or non-replicating bacilli spread throughout 
the host and, due to a high TB co-infection with HIV, it must be compatible with anti-
retroviral therapy.  Even so, some drugs are starting clinical trials such as newly 
developed fluoroquinolones, gatifloxacin and moxifloxacin, and rifapentine, a 
derivative of rifampicin that has been shown to shorten TB treatment in mice when 
used in conjunction with moxifloxacin (Cole and Riccardi, 2011; Ahmad and 
Mokaddas, 2009).   
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1.1.3 TB Vaccine 
Calmette and Guérin in the Pasteur Institute in Lille, France developed a 
vaccine for TB in 1921.  Based on an erroneous statement by Koch that M. bovis was 
not infectious to humans they chose an M. bovis, Laid Nocard strain, to use in the 
vaccine development.  It was attenuated to a non-virulent form by sub-culture of the 
bacterium on a glycerol-potato-bile medium every three weeks for thirteen years (230 
subcultures).  Due to the loss of its pathogenic potential it is considered to be a 
separate strain from M. bovis and is known as Mycobacterium bovis sbsp. Bacillus 
Calmette-Guerin (M. bovis BCG) (Chadwick, 1982; Gheorghiu, 1990).  
It was chosen as a suitable vaccine due to its retention of its immunogenicity 
and its ability to generate a delayed hypersensitivity to tuberculin and provide 
protection against virulent M. bovis.  The vaccine was first approved for use in 1928 
and to date is the only vaccine approved for use against TB. It provides a variable 
degree of protection against the disease ranging from 0-80% depending on the study, 
with most studies indicating that it provides good protection against severe forms of 
TB, such as meningitis and miliary TB, particularly in young children.  This variation 
could be due to prior exposure to environmental mycobacteria, age at vaccination 
and/or genetic factors (Chadwick, 1982; Gheorghiu, 1990; Thoen and Steele, 1995; 
Chilima et al., 2006; Hope and Villarreal-Ramos, 2008). 
Alternatives to BCG vaccination are currently being developed with the aim of 
preventing a TB infection, boosting the immune system of individuals that have a 
latent TB infection to prevent the progression of the disease and utilising a vaccine 
that can boost the effectiveness of anti-TB drugs, especially in cases of MDR-TB, 
with the latter proving most difficult to achieve (Girard et al., 2005).  Several different 
strategies are being used such as genetically modifying the M. bovis BCG strain to 
induce a greater protective immunity against TB and developing a new live vaccine 
using attenuated auxotrophic M. tuberculosis strains (Collins, 2000; Girard et al., 
2005).  Other strategies include the use of attenuated Salmonella vectors or virus 
vectors that express mycobacterial antigens to boost the effectiveness of the BCG 
vaccination such as attenuated vaccinia virus MVA strain expressing Ag85A, an 
antigen secreted by M. tuberculosis (Vordermeier et al., 2009; Girard et al., 2005). 
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1.2 Genus Mycobacterium 
1.2.1 Mycobacteria 
TB is caused by members of the genus Mycobacterium that contains 
approximately eighty-five different species.  Mycobacteria are mostly aerobic, though 
some can be microaerophilic, non-chromogenic, rod-shaped and non-motile bacteria. 
The acid-fast staining reaction is the primary test for identifying mycobacteria since 
the cells are resistant to decolourisation with a dilute mineral acid (or acid-alcohol 
solution) after staining with an arylmethane dye, such as fuchsin (Ziehl-Neelsen stain) 
(Collins et al., 1997; Grange, 1996; European Food Safety Authority, 2003; Rastogi et 
al., 2001).  
The majority of mycobacteria are free living and are found in water or watery 
environments such as mud, soil and as biofilms in water pipes.  They tend to cause 
“opportunistic” infections in humans and animals such as Buruli ulcers that are caused 
by Mycobacterium ulcerans, which enter the body through spikes on vegetation. 
Another opportunistic pathogen is the “Mycobacterium avium complex” (MAC) that 
causes pulmonary disease and can spread to other organs in the body.  It affects 
people who are immunosuppressed such as transplant recipients, AIDS and cancer 
patients. MAC includes M. avium and Mycobacterium intracellulare that are closely 
related slow growing mycobacteria (Collins et al., 1997; Grange, 1996; Rastogi et al., 
2001).  
The second group of mycobacteria are obligate pathogens; this group includes 
the members of the “Mycobacterium tuberculosis complex” (MTBC) and 
Mycobacterium leprae, which causes leprosy.  M. leprae does not have a wide host 
spectrum and is predominantly a human pathogen but it does occur in some animals 
such as the nine-banded armadillo.  Although it cannot be cultured in vitro yet, it does 
grow in the footpads of mice (Collins et al., 1997). 
 “Mycobacterium tuberculosis complex” (MTBC) has seven approved 
members and these are Mycobacterium tuberculosis, Mycobacterium bovis, 
Mycobacterium bovis BCG, Mycobacterium africanum, Mycobacterium microti, 
Mycobacterium tuberculosis sbsp. canetti and Mycobacterium bovis sbsp. caprae 
(Haddad et al., 2004; Collins, 2011). Four members of this group cause human 
tuberculosis i.e. M. bovis, M. tuberculosis, M. africanum and M canetti (Collins et al., 
1997; Collins, 2011).  Members of the MTBC are extremely similar genetically 
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having at least 99.9% similarity on the nucleotide level and an identical 16rRNA 
sequence (Brosch et al., 2002).   
 
1.2.2 Mycobacteria Structure 
Mycobacteria are similar to other bacteria in many respects except for a 
unique cell wall that is made up of four parts, Figure 1.1. The first part is a 
peptidoglycan layer that is similar to that found on other bacterial species. The second 
layer contains arabinogalactan, which is made up of branched macromolecules of 
arabinose and galactose (Grange, 1996).     
The third layer, which contributes to the thickness of mycobacterial cell walls, 
is made of mycolic acids that are long branched chains of fatty acids with differing 50 
and 30 carbon atom lengths.  The mycolic acids are responsible for the acid fast 
staining reaction of mycobacteria cells (Grange, 1996; Thoen and Steele, 1995).    
The fourth, outer, layer consists of a mixture of lipids and related compounds 
such as trehalose-containing glycolipids and peptidoglycolipids called mycosides.  
Trehalose-containing glycolipids include a “cord-factor” compound that was 
previously believed to be responsible for the “serpentine cords” of virulent MTBC but 
this was later proved to be inaccurate, Figure 1.2 (Grange, 1996).   
The mycosides on the outer layer of the cell wall have similar functions as the 
capsule in capsulated bacteria and allow mycobacterial cells to survive in less than 
ideal conditions.  M. bovis may survive depending on the environment, specifically 
exposure to direct sunlight, for period of time ranging from several days to months in 
soil, on pastures or in faeces leading to a source of infection (O‟Reilly and Daborn, 
1995). The mycosides also allow for certain mycobacteria, such as those in the MAC 
complex, to be subdivided due to an agglutination reaction to specific antisera.  The 
thick layer of mycosides on some species of mycobacteria gives them a smooth 
colony when grown on solid media and in the case of MAC the colonial morphology 
can be correlated to virulence with transparent and rough colony forming strains being 
more virulent than opaque and intermediate colony forming strains (Kuze and 
Uchihira, 1984; European Food Safety Authority, 2003).  
Another benefit of the presence of mycosides is that they may provide 
protection to intracellular organisms against the „cidal effects of intermediate oxygen 
metabolites‟ (Grange, 1996). 
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Figure 1.1: Schematic diagram of the mycobacterial cell wall. Adapted from Grange, 
1996. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Slide showing “Serpentine cords” of M. bovis made up of small, non-
motile rods 1-4µm long (Costello, 2004).  
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An important component of the cell wall is lipoarabinomannan (LAM), which 
stretches from the cell membrane up though the cell wall and is probably responsible 
for keeping the layers of the cell wall together and binding it to the cell membrane.  
LAM induces the production of different cytokines, such as tumour necrosis factor
when exposed to macrophages in a host organism and since it differs structurally 
between virulent and attenuated stains of mycobacteria it may contribute to the 
pathogenicity of a particular stain (Grange, 1996; Thoen and Steele, 1995). 
 
1.3 Bovine TB  
1.3.1 M. bovis in Cattle 
M. bovis has a broad host range that includes both wild and domesticated 
animals and is the main causative agent of TB in animals.  M. bovis was differentiated 
from M. tuberculosis by Theobald Smith, in 1896, by small but constant culture 
differences (Chadwick, 1982).  Inhalation of M. bovis bacilli is the most common 
route of infection with only a small number of mycobacteria required to cause an 
infection and spread of the infection can happen between animals when that are 
confined together in the same air space, such as during housing over the winter 
period.  A secondary source of infection is the ingestion of contaminated milk or 
contaminated pasture and water, though environmental contamination is not believed 
to be a significant source of infection for bovine TB.  Infection of the reproductive 
system can lead to genital transmission of the bacilli but this is a particularly rare 
event as is congenital infection (Thoen et al., 2006; Neill et al., 2005; Haddad et al., 
2004; Neill et al., 2001; Menzies and Neill, 2005).   
Clinical diagnosis of a TB infection, in cattle, is difficult due to the chronic 
nature of the disease and the wide variety of symptoms depending on the location of 
the infection.  In cattle, infection with M. bovis is a progressive, two stage, disease.  
The initial phase involves TB granuloma formation, which occurs at the site of 
infection and the local lymph node.  This phase is usually asymptomatic and further 
progression of the disease varies considerably in rate and route (Blood et al., 1979; 
Thoen and Steele, 1995; Budka et al., 2003).   
Healthy, TB free, adult cattle are shown in Figure 1.3 to compare to Figure 1.4 
which shows a 9 month old animal with miliary TB.  Cattle with miliary TB, in which 
the infection is spread throughout the animal, are clinically normal but suffer from 
progressive emaciation, large appetites and fluctuating temperature.  The animal, 
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Figure 1.3 Healthy, TB free, adult cattle from Abbotstown Farm (Courtesy of J. 
McGuirk). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: A 9 month old animal with miliary TB.  It was visible different to other 
animals of the age with weight loss, a rougher coat and signs of respiratory distress 
(Costello, 2004). 
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shown in Figure 1.4, was visibly different to other animals of the same age.  It was 
smaller with a rougher coat, was losing weight and was showing signs of respiratory 
distress.  The exact route of infection for the animal is unknown but was probably due 
to drinking infected milk as a calf (Blood et al., 1979; Budka et al., 2003; Costello, 
2004). 
Pulmonary TB is characterised by a chronic, low, suppressed and moist cough 
due to bronchopneumonia.  The symptoms of alimentary TB, dysphagia (difficulty 
swallowing) and noisy breathing are due to pressure of swollen lymph nodes on the 
surrounding organs (Blood et al., 1979; Budka et al., 2003).    
TB mastitis is a significant danger to public health and a route for transmission 
of the infection to calves.  This is due to the possibility that TB bacilli may be present 
in milk before clinical signs of a TB infection are obvious.  It is also difficult to 
differentiate from other forms of mastitis with the most characteristic symptoms being 
the development of hard nodules in the upper, rear portion of the udder and enlarged 
supramammary lymph nodes.  Initially milk production is reduced but physically 
normal, even with the presence of bacilli, followed by milk which contains fine 
floccules that settle out to leave a clear amber fluid.  Advanced clinical cases of the 
disease still occur but are uncommon due to the bovine eradication scheme (Blood et 
al., 1979; Thoen and Steele, 1995; Budka et al., 2003). 
  
1.3.2 M. bovis in Humans 
Due to poor experimental controls, M. bovis was initially believed not to be a 
disease of man but this was later proved to be inaccurate (Thoen and Steele, 1995).  
The consumption of unpasteurised milk from infected cattle is the primary route of M. 
bovis infection in man and is associated with nonpulmonary TB, particularly in 
children.  Cervical lymphadentitis and lupus vulgaris (chronic skin TB) are the most 
common presentations of a nonpulmonary M. bovis infection.  Pulmonary TB due to 
M. bovis is clinically, radiologically and pathologically identical to one caused by M. 
tuberculosis but it is uncommon and usually associated with animal handlers and 
abattoir workers (Thoen and Steel, 1995; Thoen et al., 2006; Neill et al., 2005). 
Human TB caused by M. bovis is unusual in countries in the developed world, 
due to the implementation of eradication programs for domesticated animals, 
accounting for <1% of TB infections (Neill et al., 2005).  There are no figures 
available to show how many TB cases are caused by M. bovis in Ireland.   However, a 
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project in Southwest Ireland (Cork and Kerry), the region that reports the highest  
annual TB cases, showed that M. bovis accounted for 3% of human TB cases in the 
years 1998-2006 (Ojo et al., 2008; National TB Advisory Committee, 2010).   
In the developing world, M. bovis is responsible for 5-10% of human TB cases 
but this varies between countries (Haddad et al., 2004).  Limited laboratory facilities, 
in most developing countries, means that bacteriological diagnosis of a TB infection 
tends to be carried out by acid-fast bacillus smear examination only, so under-
diagnosis of M. bovis infection may be occurring (Thoen et al., 2004).  Due to the 
effectiveness of the WHO recommended TB treatment regime against human M. 
bovis infections, an argument can be made that diagnosis is not necessary from a case 
management and therapy viewpoint (Michel et al., 2010). 
 
1.3.3 M. bovis in Wildlife 
In Ireland the main wildlife reservoir of M. bovis is the Badger (Meles meles), 
which is a protected species.  There is a high density of badgers in Ireland with an 
estimated population number of 200,000 animals.  TB is a chronic infection in 
badgers and in a naturally infected population disease severity varies widely; with the 
infection most commonly seen in a latent subclinical form with no visible lesions 
(NVL) on post mortem examination (Thoen and Steele, 1995; Philips et al., 2003; 
Wilson et al., 2011).  The prevalence of M. bovis in badgers varies depending on the 
source of samples, though samples are collected from wide geographical areas.  
Badgers sourced from culling operations associated with TB herd breakdowns had a 
M. bovis prevalence rate of 36.3% (78 M. bovis culture positive animals from 215 
badgers in total) (Murphy et al., 2010).  Badgers culled from areas with a low TB 
prevalence in cattle, Greenfield sites, had a lower M. bovis prevalence of 14.9% (13 
M. bovis culture positive animals from 87 badgers in total) (Murphy et al., 2011).   
The degree to which badgers contribute to TB in cattle is unclear but it is 
estimated that they are responsible for about 50% of TB infections within an 
experimental area (Jenkins et al., 2008).  The exact route of transmission of M. bovis 
from badgers to cattle is not known but may occur during direct contact with badgers 
or their excretory products.  Badgers tend to form setts in hedgerows, close to 
domesticated animals, they forage for food in fields (earthworms are a primary 
component of their diet) and in farm buildings.  When their infection reaches an 
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advanced stage they can excrete bacilli in aerosols, faeces and urine (Thoen and 
Steele, 1995; Philips et al., 2003; Wilson et al., 2011).   
The methods used to reduce the transmission of M. bovis between badgers and 
cattle include culling, vaccination and bio-security measures to prevent contact 
between badgers and cattle.  Reactive culling takes place in Ireland where badgers are 
removed under license from a 1-2km area around a farm which has suffered a herd 
breakdown.  This has been shown in studies, particularly the Four Areas Project, to 
reduce the TB prevalence in cattle herds (Griffin et al., 2005).  Field trials have begun 
on the use of a BCG vaccine in badgers but development work still needs to be carried 
out to determine an effective dose in wild badgers, the optimum delivery method and 
environmental impact so a reduction of TB infection rates will take time (Wilson et 
al., 2011; Gormley and Corner, 2011).  Bio-security measures, such as badger-proof 
gates and electric fences, are slow to be implemented by farm owners due to the 
expense and the unknown usefulness of such measures in preventing a TB herd 
breakdown (Wilson et al., 2011).                                                                                                        
Other wildlife reservoirs of the disease include deer with a TB prevalence of 
approx 5% of the population (Clifton-Hadley and Wilesmith, 2005).  Deer are not 
believed to be a significant source of M. bovis in cattle in Ireland however they can be 
a source of infection in other countries such as with the red deer (Cervus elaphus) in 
Spain and the white tailed deer (Odocoileus virginianus) in Michigan, particularly 
when herds of wild deer are maintained on large estates for hunting and regularly 
come into contact with farmed animals (Castillo et al., 2011; Miller et al., 2005).  
Improved fencing to prevent farmed cattle from entering woodland areas and to deter 
wild deer from cattle pastures is the currently the main strategy for prevention disease 
transmission since control of TB in wild deer is impractical at the current time 
(Clifton-Hadley and Wilesmith, 2005).  In New Zealand, where the brush-tailed 
possum is the main wildlife reservoir of M. bovis, wild deer are believed to act as a 
vector for tuberculosis, contracting the disease when they travel though areas 
occupied by infected possums and as they move on spreading the infection to non-
infected possum groups (O‟Reilly and Daborn, 1995).   
A wildlife survey in England confirmed M. bovis infection in a wide variety of 
wild mammals including grey squirrel, fox and wood mouse (Delahay et al., 2007). 
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1.3.4 Bovine TB Eradication Scheme 
The M. bovis eradication scheme began in Ireland, on a voluntary basis, in 
1954 and became compulsory in 1957.  M. bovis infectious status of Irish cattle herds 
was estimated to be 17% at that time in Ireland.  
The eradication scheme involved monitoring the TB status of cattle herds, on 
an annual basis, using the Single Intradermal Comparative Tuberculin Test (SICTT).  
The SICTT works by the generation of a measurable response to purified protein 
derivative (PPD) following intradermal injection.  Both bovine and avian tuberculin 
PPDs are used in combination.  Some animals, due to their own immune systems, do 
not respond to the test regardless of their infection status.  Other animals, that are 
infected with M. bovis become anergic with suppression of the cellular immune 
response in the blood and at the site of the infection and do not show any response to 
the skin test.  Herds are deemed to be experiencing a TB breakdown if an animal 
responds to the SICTT i.e. are identified as a „reactor‟.  Positive reactor animals were 
removed from the herd and slaughtered with the owner being paid compensation for 
the loss of the animal (Daly, 2002; Thoen and Steele, 1995; Good and Duignan, 
2011).   
Another element of the eradication scheme was the diagnosis of TB in 
slaughtered cattle, provided as part of a meat hygiene and inspection service by the 
Department of Agriculture and Food.  As part of a meat inspection, visual 
examinations of pleura, peritoneum and the split vertebral column are carried out to 
detect TB granulomas, see Figure 1.5.  Incisions are made into the carcass lymph 
nodes, in particular the bronchial and mediastinal lymph nodes, for the same purpose.   
Any suspect TB lesions detected are removed and sent to the Central Veterinary 
Research Laboratory (CVRL) for confirmatory testing (Budka et al., 2003).    
Meat Inspections are an important part of the scheme, since, in any single 
year, during 1993-2001, between 27% and 46% of all new herd TB breakdowns were 
detected by meat inspectors (More and Good, 2006).  A study carried out during meat 
inspections for reactor animals during 1982-1990, showed the majority of TB visible 
lesions detected were associated with a respiratory route of infection, 57% of cattle, 
averaged annually, had lesions confined to bronchial and/or mediastinal lymph nodes, 
Figure 1.6, with a further 23% associated with head lymph nodes (retropharyngeal 
and submaxillary) (Neill et al., 1994).  It should be noted that a significant percentage 
of animals that give a positive reaction to the SICTT have no visible lesions detected 
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Figure 1.5: Tuberculosis pleurisy and lung lesion (from the animal shown in Figure 
1.4) (Costello, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6:  Tuberculosis lesion in a lymph node tissue sample (Costello, 2004). 
4cm 
4 cm 
33 
 
during an abattoir meat inspection, between 8-10% in Ireland and the United 
Kingdom.  This may be due to a non-specific reaction of the SICTT, as a result of 
exposure of the animal to environmental mycobacteria, or the presence of very small 
TB lesions in the lung or other tissue that cannot be detected except by a more 
detailed examination than would routinely take place during a meat inspection (Neill 
et al., 2001; Monaghan et al., 2005).   
The combination of SICTT use for TB screening, abattoir meat inspections, 
laboratory monitoring of suspect tissue samples and improved animal husbandry 
methods lead to an improvement in animal health.  In 1965 the national herd was 
declared free of M. bovis infection due to a drop in the level of TB infection in herds 
to 3%.  To date, the eradication scheme has failed to reduce the incidence of TB 
below this level, with the percentage of TB infected herds in Ireland standing at 
5.17% in 2009, for a number of reasons.  These include the limitations of the 
tuberculin skin test and the presence of wildlife reservoirs of infection, such as 
badgers, which provides a means of re-infection of a TB free herd (European Food 
Safety Authority, 2011; Thoen and Steele, 1995).    
 
1.4 Laboratory Detection of M. bovis infection 
1.4.1 Direct Smears 
The fastest and simplest method of confirming a mycobacterial infection is a 
direct acid-fast bacilli (AFB) smear examination from a suspect sample.  A Ziehl-
Neelsen (ZN) stain or auramine stain using fluorescent microscopy can be used to 
determine this.  Both stains work on the simple principle that any mycobacteria 
present in the smear retain an arylmethane dye, such as carbol fuchsin or a fluorescent 
analogue, within the cell giving an acid-fast staining reaction, following treatment 
with a weak acid-alcohol solution. This is due to the mycolic acids in the bacterium‟s 
thick cell wall (Grange, 1996; Collins et al., 1997). 
This procedure is best used to diagnose pulmonary TB from sputum, in areas 
with high TB infection and limited laboratory resources.  Diagnosis of TB infection 
from tissues, faeces or other biological material with this technique is poor due to low 
numbers of mycobacteria and sample contamination with other acid-fast bacteria.  
Direct staining does not provide any information on the species of mycobacteria 
causing the infection or differentiate between viable and non-viable cells (Thoen and 
Steele, 1995; Collins et al., 1997). 
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1.4.2 Histology 
Mycobacterial infection can be diagnosed with histopathological examination 
of tissue samples.  A TB infection such as M. bovis in cattle causes characteristic 
cellular changes to the tissues which can be identified with experience and training.  
The most efficient stain for this purpose is a hematoxylin and eosin (H&E) stain 
(Thoen and Steele, 1995).  An example of a tuberculosis granuloma, which has 
caseous necrosis in the centre surrounded by an area of epithelioid cells, lymphocytes 
and some granulocytes with multinucleated giant cells near the necrotic area, from a 
lymph node tissue is shown in Figure 1.7.  A correlation of 94% was found between 
the use of histopathology and culture to diagnose M. bovis infection in cattle 
(Costello, 2004).  A weakness with this method is that other bacteria or mycobacteria 
can induce similar lesions to those caused by bovine tuberculosis and that a M. bovis 
infection in other animals may not cause the same cellular changes as those seen in 
cattle making diagnosis more difficult (Thoen and Steele, 1995). 
Rhodococcus equi, an environmental microorganism found in soil, is an 
opportunistic pathogen that can cause a granuloma similar, on visual examination, to a 
TB granuloma in the lymph nodes of cattle.  It is possible to distinguish a R. equi 
granuloma from a TB granuloma by histopathological examination of the tissue 
however a definitive diagnosis requires bacteriological examination.  R. equi is able to 
resist decontamination with 5% oxalic acid, due to the presence of mycolic acids in 
the cell wall similar to that of the genus Mycobacterium, though the number of viable 
bacteria will be reduced.  As a result of its cell wall structure, R. equi is isolated 
during TB culture, Figure 1.8 shows R. equi growing on blood agar (Flynn et al., 
2001; Rahman et al., 2003). 
 
1.4.3 Culture 
Culture of mycobacteria can provide more information on the mycobacterial 
infection than a direct smear or histopathology. Most mycobacteria grow on media 
that provides a carbon and nitrogen source and mineral salts that supply phosphorus, 
sodium, potassium, sulphur, iron and magnesium.  Impurities in the media provide a 
supply of any trace elements required for growth.  Most mycobacteria require 
atmospheric oxygen for growth but some such as M. bovis are microaerophilic 
(Grange, 1996; European Food Safety Authority, 2003). 
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Figure 1.7:  Tuberculosis granuloma, showing caseous necrosis (CN) and 
multinucleated giant cells formed due to macrophage fusion (arrows), from lymph 
node tissue stained with H&E stain (Costello, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: R. equi growth on a blood agar plate (Costello, 2004). 
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Due to the slow growth rate of some mycobacteria, M. bovis can take 14-21 
days of culture prior to growth detection; the culture media can become 
overgrown with contaminating bacteria and fungi if present in the inoculum (Corner 
and Trajstman, 1988).  To prevent contamination the specimen for culture must be 
decontaminated prior to inoculation.  The mycobacteria cell wall allows the bacterium 
to be relatively resistant to biocides used in decontamination procedures (Chilima et 
al., 2006).   
The choice and method of decontamination is critical with the ideal one 
having no effect on the viability of the mycobacteria but an ability to kill all 
contaminating micro-organisms (Corner et al., 1995).  However no reagent or 
procedure is capable of fulfilling this requirement and a compromise must be made to 
ensure enough mycobacteria survive to propagate in culture even if some cultures 
become contaminated. A contamination rate of between 2-10% is acceptable 
depending on the type of sample, age of sample prior to culture and transport 
conditions (Collins et al., 1997).   
Different decontamination protocols have been evaluated for the pre-treatment 
of tissue samples prior to culture for MTBC.  These include 2% sodium hydroxide 
(NaOH), 5% oxalic acid (OA) and 0.075% and 0.75% cetylpyridinium chloride 
(CPC).  The use of 2% NaOH, which is recommended by the Centres for Disease 
Control and Prevention (CDC) for use on tissue samples, is an effective method but it 
requires the addition of a neutralization step prior to inoculation onto culture media 
which increases the decontamination time (Collins et al., 1997).   
A study carried out that compared several decontamination reagents concluded 
that CPC, at different concentrations depending on the risk of contamination in the 
sample, was the most suitable method for use on tissues for isolation of M. bovis 
using solid culture media (Corner et al., 1995).  Further work, carried out by the 
Veterinary Laboratories Agency in England, showed that CPC, when used to 
decontaminate tissues during transport to the laboratory, was toxic to M. bovis, when 
grown on solid culture media, at concentrations below 0.32%, which is its Critical 
Micellar Concentration (CMC) (Brown et al., 2005).  CPC has been shown to inhibit 
growth of M. bovis on the BACTEC 460 liquid culture system when compared to 5% 
oxalic acid (McLernon et al., 2004).   
 
37 
 
1.4.4 Culture Media 
Since no single medium can isolate every mycobacterium within a sample, 
culture is normally carried out using a combination of liquid and solid culture media.  
Solid media used can be egg-based, Lowenstein-Jensen (LJ) and Stonebrinks, an 
example of M. bovis growth is shown in Figure 1.9, or agar based, Middlebrook 7H10 
and Middlebrook 7H11, an example of M. bovis growth is shown in Figure 1.10. 
Culture on solid media has an added advantage in that it can also provide 
information about the species of mycobacterial growth without carrying out any 
biochemical or molecular tests.  MTBC grows only when incubated at 37
o
C +/- 1
o
C, 
whereas other mycobacteria can grow at different temperatures.  Addition of pyruvate 
to LJ medium (LJP) will support the growth of M. bovis while addition of glycerol to 
LJ medium (LJG) will support the growth of M. tuberculosis but inhibit the growth of 
M. bovis (Collins et al., 1997). 
Liquid culture can be carried out on Kirchner media and Middlebrook 7H9 
broth, which can be modified by the addition of supplements such as antibiotic 
mixtures and growth promoters to improve mycobacterial growth (Collins et al., 
1997).  Liquid culture systems have many advantages, several studies have shown that 
they have a shorter time to detection and have a higher recovery rate of mycobacteria 
when compared to solid culture.  This difference may be due to the added enrichment 
of the liquid culture media or the ability of bacteria within a liquid medium to spread 
though the media and access all the nutrients whereas with solid media, bacteria are 
limited to the nutrients in the vicinity of the colony.  The disadvantages of liquid 
culture systems are the high cost and the requirement for specialised equipment to 
monitor the cultures.  The use of solid media with liquid culture does increase the 
recovery rate of mycobacteria when compared to liquid culture alone.  The actual 
improvement varies between studies from 1% - 8% depending on which culture 
systems are being compared (Zuhre Badak et al., 1996; Kanchana et al., 2000; 
Yearsley et al., 1998; Stager et al., 1991; Scarparo et al., 2002; Hines et al.,  2006).   
Liquid culture systems include the BACTEC 460, Figure 1.11, and BACTEC 
Mycobacterial Growth Indicator Tube 960 (MGIT 960), Figure 1.12, both of which 
are based on enriched Middlebrook 7H9 broth and supplemented with antibiotics and 
growth promoters, such as OADC (Olecate-Albumin-Dextrose-Catalase) and POES 
(Polyoxyethlene sterate).  The BACTEC 460 system is a semi-automated liquid 
culture system, in which growth is indicated by the detection of radioactive CO2 that   
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Figure 1.9: M. bovis growth on Stonebrinks media (Costello, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10: M. bovis growth on 7H11 (courtesy of J. McGuirk). 
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Figure 1.11:  BACTEC 460 Instrument (Costello, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12 BACTEC MGIT 960 Instrument (Courtesy of J. McGuirk) 
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is produced when C
14
 labelled palmitic acid, incorporated in the medium, is 
metabolised (Yearsley et al., 1998).  The MGIT 960 is a fully automated culture 
system that monitors microbial growth by the use of an O2 quenching fluorescent 
sensor, embedded in the base of the culture tube, Figure 1.13 (Scarparo et al., 2002).   
 
1.4.5 Culture Isolate Identification 
When a liquid culture system signals positive a ZN stain is carried out, to 
detect if any AFB are present, and a blood agar plate is inoculated, to determine if the 
positive signal is caused by R. equi infection or contamination with other bacteria or 
fungi.  The morphology of any AFB present is recorded.  Within the CVRL, when 
AFB are identified on a ZN stain the liquid media is sub-cultured, as described below, 
and tested with the GenProbe AccuProbe system.  
  Colonies growing on solid media are examined for typical M. bovis 
morphology, as shown in Figure 1.9, or that of R. equi, as shown in Figure 1.14., or 
contamination.  A ZN stain is carried out when examination of the colony 
morphology is inconclusive.  All suspect mycobacteria from solid media are sent for 
testing with the GenProbe AccuProbe kit.   
For sub-culture, the liquid media is inoculated onto 4 solid media; 3 
Stonebrinks or LJP media, one each incubated at either 25
o
C, 37
o
C or 45
o
C, and 1 
Lowenstein-Jensen with 500µg/Ml paranitrobenzoic acid (PNB) media, incubated at 
37
o
C.  MTBC grows only when incubated at 37
o
C +/- 1
o
C so any growth on the 25
o
C 
or 45
o
C subculture indicates a non-MTBC organism in the culture (Collins et al., 
1997).  This is also indicated by growth on the PNB media since paranitrobenzoic 
acid inhibits growth of the MTBC but allows other mycobacteria to grow (Gross and 
Hawkins, 1985).  
The GenProbe AccuProbe system utilises species-specific DNA probes to 
hybridise with ribosomal RNA (rRNA) released from bacterial cultures.  The probes 
are labelled with a chemiluminescent label; acridinium ester, and any labelled DNA: 
RNA hybrids are measured with a luminometer.  The AccuProbe kits are widely used, 
easy to perform, fast since the test can be completed in 2 hr, highly sensitive and 
specific (Neonakis et al., 2008; Soini and Musser, 2001).   
Depending on the results of the sub-cultures and GenProbe AccuProbe system 
mycobacteria isolates are reported as; MTBC, M. avium or atypical
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Figure 1.13 BACTEC MGIT 960 culture media tube (Costello, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14 R. equi growth on Stonebrinks media (Courtesy of J. McGuirk). 
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mycobacteria isolates.  Due to the limited resources and the need to maintain the 
sample turnaround time within the CVRL, strain typing is not routinely carried out. 
When contamination is detected on solid media, the media tube is discarded.  
When contamination is identified, on a liquid culture system, within the first 3 weeks 
of culture the sample is decontaminated for a second time or treated with antibiotics, 
(VCAT (Vancomycin, Colistin, Anisomycin and Trimethoprim), Becton-Dickinson, 
Cat No.: 212404) depending on the liquid culture method used.  If contamination is 
identified after 3 weeks, the culture is removed from routine monitoring, incubated at 
37
o
C and a terminal ZN (TZN) stain is carried out at the end of the 7 week culture 
period.   
If R. equi growth is detected on solid media the result is recorded and the solid 
continues to be routinely monitored for any additional colony types.  When R. equi is 
isolated, from a liquid culture system, the culture is removed from routine monitoring, 
incubated at 37
o
C and a TZN stain is carried out at the end of the 7 week culture 
period.   
If no AFB are present in the TZN stain the sample is reported as a R. equi 
isolate or as a „no isolate‟ in the case of contamination.  When AFB are identified in 
the TZN stain, the sample is sub-cultured and tested with the GenProbe AccuProbe 
system.  Mixed isolates in liquid culture systems are not unusual due to the slow 
growth rate of some mycobacteria.  A summary of the handling of suspect TB tissues 
is shown in Figure 1.15. 
 
1.4.6 Molecular Methods 
As stated previously, strain typing is not routinely carried out within the 
CVRL.  Strain typing would be done on isolates required for epidemiological studies 
to attempt to trace the source of the infection, in particular to determine if a wildlife 
reservoir was the source or if cattle-to-cattle transmission had occurred.  Several 
techniques have been developed for this purpose including Restriction Fragment 
Length Polymorphism (RFLP), spoligotyping and mycobacterial interspersed 
repetitive unit-variable-number tandem repeats (MIRU-VNTR).   
RFLP involves a restriction enzyme digest of the genomic DNA, the digested 
products are separated on an agarose gel, transferred onto a filter and hybridised with 
different probes.  A high level of discrimination between different strains of M. bovis 
has been shown with RFLP when each isolate is analysed with a combination probes  
43 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15 Summary of the handling of suspect TB positives tissues
44 
 
to the insertion sequence IS6110 and the repetitive DNA elements including the 
polymorphic GC-rich sequences (PGRS) and the direct repeat (DR) region.  This 
technique requires a large amount of DNA, is technically demanding and time 
consuming with the production of complex banding patterns that make interpretation 
and inter-laboratory comparisons difficult (Collins, 2011; Durr et al., 2000; Kanduma 
et al., 2003; McLernon et al., 2010).  
Spoligotyping involves PCR amplification of the DR (Direct Repeat) region, 
hybridization of the resulting product onto a set of immobilised oligonucleotides, that 
correspond to one of 43 unique DNA spacer sequences within the DR region, and 
detection of the hybridized DNA by a chemiluminescent system.  The test is rapid, 
easy to perform and the results can be expressed in a digital format.  However it does 
not have the same discriminatory ability for M. bovis as RFLP (Restriction Fragment 
Length Polymorphism) and tends to be used as a screening technique (Collins, 2011; 
Durr et al., 2000; Kanduma et al., 2003; McLernon et al., 2010). 
MIRU-VNTR involves the amplification of different variable number tandem 
repeat sequences, there have been 41 of these regions identified for M. tuberculosis 
and termed the mycobacterial interspersed repetitive units (MIRU), and the size of the 
product is determined by gel electrophoresis.  This technique is a useful alternative to 
RFLP analysis for M. bovis strain differentiation since it is easy to perform and, 
similar to spoligotyping, provides results that can be expressed in a digital format 
making inter-laboratory comparisons easier.  The technique can differentiate between 
M. bovis strains with an analysis of as few as 6 loci but analysis of 13 loci have been 
shown to give optimum discrimination (Collins, 2011; Durr et al., 2000; Kanduma et 
al., 2003; McLernon et al., 2010). 
The use of these techniques for direct detection of M. bovis from clinical 
lymph nodes is limited without a method for the extraction of the organism or the 
MTBC DNA from the tissue.  This is required since excess DNA inhibits a PCR 
reaction.  Lymph node tissue contains a source of host contaminating DNA and could 
also be a source of PCR inhibitors.  Since bovine tuberculous tissues commonly 
contain low numbers of acid-fast bacilli, diluting the sample to reduce host 
contaminating DNA and PCR inhibitors will also dilute the target mycobacterial DNA 
(Mangiapan et al., 1996; Roring et al., 2002).  Any extraction method used will be 
hampered by lymph node tissue, which shows strong fibrosis and calcification, 
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limiting access to any mycobacterial cells within the tissue (Liébana et al., 1995; 
Butcher et al., 1996).   
Direct detection methods, for M. bovis diagnosis, have been developed for use 
on samples with a moderate to high mycobacteria load and in cases were rapid TB 
diagnosis is important.  They have been shown to be unreliable when used on tissues 
with low numbers of organisms.  This unreliability has also been shown for direct 
detection M. tuberculosis diagnosis from clinical samples, so much so that clinical 
guidelines advise that direct detection methods that give a negative result cannot 
exclude the possibility of a tuberculosis infection.  Advances continue on improving 
DNA extraction methods and increasing PCR sensitivity however replacing culture, 
as the gold standard of TB diagnosis, remains a long-term goal (Neonakis et al., 2008; 
Collins, 2011). 
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Aims of Study  
 
The overall aim of this study was to evaluate new culture and molecular 
methods for the detection of MTBC, ideally M. bovis, in lymph node tissue within the 
Central Veterinary Research Laboratory (CVRL).  The objectives were: 
1) To determine if the MGIT 960 liquid culture system can support the growth of 
M. bovis when spiked into bovine lymph node tissue. 
2) To determine if the MGIT 960 system, for MTBC culture from LN (lymph 
node) tissues, would be a suitable replacement for the BACTEC 460 liquid 
culture system based on the ability to support growth of mycobacteria, 
specifically MTBC, labour requirements and safety concerns.   
3) If the MGIT 960 system is a suitable replacement for the BACTEC 460 
system for MTBC culture from LN tissue, to determine if CPC 
decontamination is an appropriate method to use with this culture system. 
4) To evaluate several different methods for the extraction and detection of 
mycobacterial DNA from LN tissues following decontamination for use with 
high priority samples, that would benefit from a faster turnaround time, such 
as singleton reactors and from animals with suspected human TB involvement.  
The techniques to be evaluated were: 
a) Heat Lysis  
b) Roche High Pure PCR Template Preparation Kit  
c) Immunomagnetic Separation (IMS)  
d) HAIN GenoType Mycobacteria Direct kit 
e) Sequence Capture PCR  
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All work with suspect positive tuberculosis tissues and cultures was carried 
out in a Class 1 Biological Safety Cabinet (BSC) (Medical Air Technology Ltd., 
TriMAT Class 1 Safety Cabinet).  Suitable PPE (Personal Protective Equipment) was 
worn at all times when handling any biological material. 
 
2.1 Decontamination of Lymph Node (LN) Tissue with 5% Oxalic Acid 
LN tissue samples were removed from -20
o
C freezer and allowed to defrost 
overnight at room temperature.  The samples were transferred to a filter lined 
stomacher bag (Grade Plastics Ltd., Cat No.: Grade Sep 400) and approximately 30 
ml of 5% OA (Oxalic Acid), made by dissolving 500 g of oxalic acid dihydrate 
(Merck, Cat No.: CE495.0500) in 10 L of distilled water, was added to each bag.  
Two bags at a time were placed in a stomacher (Seward Stomacher 80 Lab Systems) 
and homogenized for 2 min.  The homogenate was decanted into a 20 ml sterile tube 
(Sparks Lab Supplies, Cat No.: SLS7518).  Sample tubes were transferred to a 37
o
C 
incubator and left for 20 min.   
After incubation the samples were centrifuged (Hettich Rotanta 460R 
Centrifuge) for 15 min at 1970 g.  The supernatant was discarded and each pellet was 
resuspended in 20 ml of sterile saline (Oxoid, Cat No.: BR0053).  The tubes were 
centrifuged for 25 min at 1970 g and the supernatant discarded.  
 A sterile swab (Sparks Lab Supplies, Cat No.: SW001) was used to inoculate 
part of the pellet onto one Stonebrinks (Media for Mycobacteria) and one Lowenstein 
Jensen Medium with Pyruvate (LJP - Media for Mycobacteria, Cat No.: NaP2) 
medium, which were incubated at 37
o
C and visually checked for growth once a week.  
The remainder of the pellet was resuspended in 2 ml of sterile PBS (Oxoid, Cat No.: 
BR0014) and vortexed for 15 sec.   
Just prior to inoculation 0.8 ml of MGIT PANTA (antibiotic mixture of 
Polymyxin B, Amphotericin B, Nalidixic acid, Trimethoprim, Azlocillin - Becton-
Dickinson, Cat No. BD245124), lyophilized PANTA mixture reconstituted with 
OADC (Olecate-Albumin-Dextrose-Catalase), was added to a MGIT tube (Becton-
Dickinson, Cat No.: 245122) and 0.1 ml of PANTA (Becton-Dickinson, Cat No.: 
BD444764), lyophilized PANTA mixture reconstituted with POES (Polyoxyethlene 
sterate), was added to a BACTEC 460 bottle (Becton-Dickinson, Cat No.: 442004).   
A 1 ml luer-lock syringe (Fannin Healthcare, Cat No.: FB309628.30128) was 
used to add 0.2 ml of the decontaminated pellet solution to a BACTEC 460 bottle and 
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the bottle was transferred to a 37
o
C incubator.  A 3.5 ml transfer pipette (Sarsteadt, 
Cat No.: 86.1172.001) was used to add 0.5 ml of the pellet solution to a MGIT tube 
and the tube was scanned into the MGIT 960 Instrument (BD Diagnostic Systems, Cat 
No.: 445870) and monitored continuously by the instrument.  The BACTEC 460 
bottle was monitored in the BACTEC 460 machine (BD Diagnostic Systems) twice a 
week for the first 3 weeks and once a fortnight for the remaining 4 weeks.  The 
remainder of the pellet was stored at -20
o
C.  
 
2.2 Decontamination of LN Tissue with 10% OA 
LN tissue samples were removed from -20
o
C freezer and allowed to defrost 
overnight at room temperature.  The samples were transferred to a filter lined 
stomacher bag and PBS was added to each bag. Two bags at a time were placed in a 
stomacher and homogenized for 2 min.  The resulting solution, 10 ml, was decanted 
into a 20 ml sterile tube and 10 ml of 10% OA, made by dissolving 100 g of OA 
dihydrate in 1 L of distilled water, was added to each tube to give a final 
concentration of 5% OA.  The culture procedure was carried out from this point as per 
section 2.1. 
 
2.3 Preparing a smear from a suspect positive MGIT tube 
The MGIT 960 Instrument indicated that a tube has become positive, caused 
by the detection of fluoresce at the base of the sample tube due to oxygen depletion 
within the media, by an alarm and a red light on the front panel of a drawer.  The 
flagging tube was scanned out of the machine and transferred to a BSC (Biological 
Safety Cabinet).  Samples monitored with the MGIT 960 Manual Reader (BD 
Diagnostic Systems) indicated a positive tube by a reading of 14 or higher on the 
scale on the front of the reader (no units given).   
A portion of the pellet was removed from the base of the tube by means of a 
transfer pipette.  A few drops were placed on a glass microscope slide and the 
remainder was inoculated onto a blood agar plate.  Blood agar plates were prepared 
by dissolving 37 g of blood agar base (Lab M, Cat No.: Lab 28) in 1 L of deionised 
water, autoclaving at 121
o
C for 15 min, after the media had cooled to 48
o
C, 5-7% 
defibrinated horse blood (TCS Biosciences, Cat No.: HB034) was added, the plates 
were poured, allowed to set at room temperature for at least 3 hr and stored at 4
o
C 
until ready for use.  The blood agar plate was incubated at 37
o
C and checked for 
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bacterial growth after 24 hr and 48 hr of incubation.  The slide was heated to 80
o
C for 
90 min on a slide heater placed in the BSC and a ZN stain was then carried out. 
 
2.4 Preparing a smear from a suspect positive BACTEC bottle 
When the growth index (GI), measured by the BACTEC 460 machine, gave a 
reading  above 20 a positive signal was recorded, however a smear for a ZN stain was 
not prepared until the GI reading was 50 or higher.  A 1 ml syringe was used to 
remove 0.5 ml of the liquid from a BACTEC bottle in a BSC.  The liquid was 
centrifuged, in a 1.5 ml screw-cap tube (Sarsteadt, Cat No.: 72.692.005) at 15200 g 
for 10 min.  Most of the liquid was discarded and the remainder was used to 
resuspend the pellet.  A smear and a blood agar plate were prepared as per section 2.3 
above. 
 
2.5 ZN Stain 
The slide was flooded with concentrated carbol fuchsin (Difco, Cat No.: 
212511) and heated by means of an alcohol soaked taper until steaming. Care must be 
taken during this process that the carbol fuchsin does not boil on the slide.  The stain 
was left for 10 min and washed with water.  An acid-alcohol solution, prepared by the 
addition of 20% sulphuric acid, 50ml, (Sigma, Cat No.: 320501, diluted with distilled 
water) to 950 ml of 85% ethanol (Sigma, Cat No.: E7023, diluted with distilled 
water), was placed on the slide and allowed to decolourise for 5 min.  The slide was 
washed with water and counterstained with a 0.5% malachite green solution (Merck, 
Cat No.: 15942) for 2 min.  The slide was washed with water and allowed to dry. 
 
2.6 Serial Dilution of M. bovis stock   
M. bovis stock solution was removed from the –80oC freezer and allowed to 
defrost at 4
o
C.  The stock had been stored in a mixture of glycerol and PBS (50:50).  
When fully defrosted the tube was centrifuged at 1970 g for 25 min and the 
supernatant discarded.  The pellet was resuspended in an equal volume of PBS-Tw 
(approx. 2.5 ml).  The PBS-Tw was prepared by the addition of 1 ml of Tween 80 
(Sigma, P-1754) to 1 L of PBS and autoclaved at 121
o
C for 15 min.  An aliquot of the 
M. bovis stock solution, 1 ml, was inoculated into 9 ml of PBS-Tw and vortexed for 
30 sec.  A serial 1/10 dilution was carried out down as far as 10
-10
 dilution. 
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2.7 Limits of Detection of M. bovis  
Approximately 35 g of negative LN tissue, split into two aliquots, was 
stomached in PBS as described in section 2.2. The homogenized LN tissue solution 
was mixed to form an even suspension that was split into eleven 9 ml aliquots.  Each 
aliquot was spiked with 1 ml of the M. bovis stock serial dilution (section 2.6) and 1 
ml of PBS-Tw was added to the final tube to act as a negative control.  A 10% Oxalic 
acid solution, 10 ml, was added to each tube and the decontamination procedure was 
carried out as in section 2.2. 
After decontamination the pellets were resuspended in 6 ml of PBS-Tw and 
vortexed for 30 sec.  The pellet solution, 0.2 ml, was added to three 7H11 plates that 
were then sealed with parafilm and incubated at 37
o
C for 28 days.  After incubation 
the colonies on each plate, were counted and this was used to determine the cfu/ml as 
per equation below. 
Cfu/ml = average of plate colony count x 5 x 10 x dilution factor. 
The 7H11 plates were prepared by the addition of 18.9 g Middlebrook 7H11 
powder (Difco, Cat No.: 283810), 2 g of Bacto Agar (BD, Cat No.: 214010) and 1 ml 
of 0.05% malachite green solution to 789 ml of deionised H2O.  The medium was 
autoclaved at 121
o
C for 15 min, allowed to cool to 50
o
C before the addition of 100 ml 
of denatured Adult Bovine Serum (Sigma, Cat No.: B-9433, heated to 60
o
C for 60 
min) and dissolved Krichner Mycobacteria Selectabs (Mast Diagnostics, Cat No.: 
MS24, 2 tablets dissolved in 10 ml of sterile H2O).  The plates were poured, allowed 
to set at room temperature for at least 3 hr and stored at 4
o
C until ready for use. 
A total of six MGIT 960 tubes were also inoculated with 0.5 ml of the pellet 
solution and 0.2 ml of the pellet solution was added to six BACTEC 460 bottles. 
 
2.8 Subculture of Suspect Mycobacteria 
When AFB were seen on examination of a ZN stained slide, from a liquid 
culture sample, a few drops of the liquid culture medium was inoculated onto 3 tubes 
(either Stonebrinks or LJP) and 1 Paranitrobenzoic Acid Medium (PNB – Media for 
Mycobacteria).  Each Stonebrinks or LJP was incubated at three temperatures, 25
o
C, 
37
o
C and 45
o
C, and the PNB medium was incubated at 37
o
C.   
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2.9 GenProbe (GP) AccuProbe (AccuP) MTBC, MAC and M. avium Testing Kits 
(bioMérieux, Cat No.: MTBC kit - 39000, MAC kit – 39001, M. avium kit – 39305). 
All isolates with suspect mycobacterial growth on solid media or with AFB 
present on a ZN stain are tested with the MTBC AccuP kit.  Samples that have non-
corded or diffuse AFB are also tested with a MAC AccuP kit and a positive result on 
the MAC AccuP kit prompts the use of the M. avium AccuP  kit. 
All of the liquid, except approximately 0.5 ml, was removed from the MGIT 
960 tube or BACTEC 460 bottle to be tested and centrifuged at 1970 g for 30 min.  
The supernatant was discarded and the pellet was re-suspended in 100 µl of Reagent 1 
(Lysis Reagent, GP Culture Identification kit - bioMérieux, Cat No.:  39305) and 100 
µl of Reagent 2 (Hybridization Buffer, GP Culture Identification kit).  The solution 
was transferred, using a 3.5 ml transfer pipette, to the Lysing Reagent Tube (GP 
AccuP kit).  For use of the kit with solid culture media, a loopful of culture from a 
suspect positive solid was transferred to the Lysing Reagent Tube to which Reagents 
1 and 2 had previously been added.   
The Lysing Reagent Tube was briefly vortexed and transferred to a water bath 
sonicator (VWR, Model No.: USC300D), in which the water had been degassed 
thoroughly before use, and sonicated for 15 min.  After sonication, the tube was 
transferred to heating block (Test Tube Heater SHTD, Stuart Scientific) and heated 
for 10 min at 95
o
C ± 5
o
C.  
The solution, 100 µl, from the Lysing reagent tube was transferred to the 
Probe Reagent Tube (GP AccuP kit) and incubated at 60
o
C ± 1
o
C for 15 min in a 
heating block.  Reagent 3 (Selection Reagent, GP Culture Identification kit), 300 µl, 
was added to the Probe Reagent Tube and vortexed.  The tube was then incubated, in 
a heating block, at 60
o
C ± 1
o
C for 5 min, when using the MAC and M. avium kits, or 
for 10 min, when using the MTBC kit.  The Probe Reagent Tube was removed from 
the heating block and allowed to cool at room temperature for at least 5 min.  
The GP Leader 50i Luminometer (GenProbe, Cat No.: 103100i-02) was 
primed for use with Detection Reagents I and II (GP Detection Reagent kit - 
bioMérieux, Cat No.:  39300).  After the Probe Reagent Tube had been allowed to 
cool, it was inserted into the Luminometer and analysed.  Any sample which 
produced a signal equal to or greater than the cut-off value of 30,000 RLU (Relative 
Light Units) was considered positive.  
53 
 
All isolates with suspect mycobacterial growth on solid media or with corded 
AFB present on a ZN stain are tested with the MTBC AccuProbe kit (bioMérieux, Cat 
No.: 39000). 
Non corded or diffuse AFB are tested with a MAC AccuProbe kit 
(bioMérieux, Cat No.: 39001) 
  A positive result on the MAC AccuProbe kit prompts the use of the M. avium 
AccuProbe kit (bioMérieux, Cat No.: 39305).   
 
2.10 Decontamination of LN tissue with 0.75% CPC 
LN tissue samples were removed from -20
o
C freezer and allowed to defrost 
overnight at room temperature.  The samples were transferred to a filter lined 
stomacher bag and PBS was added to each bag.  Two bags at a time were placed in a 
stomacher and homogenized for 2 min.  The resulting solution, 10 ml, was decanted 
into a 20 ml sterile tube.  An equal volume of 1.5% CPC, prepared by dissolving 15 g 
of CPC (Sigma, Cat No.: C-9002) in 1 L of distilled water, autoclaving for 15 min at 
121
o
C and storing the solution at room temperature, was added to each tube to give a 
final concentration of 0.75% CPC.  The samples were incubated at room temperature 
for 30 min and the remainder of the decontamination procedure was carried out as per 
section 2.1.   
 
2.11 Preparation of Decontaminated Tissue Samples 
Thirty lymph node tissues were decontaminated with 5% oxalic acid and 
cultured as per section 2.1, with 6 ml of PBS being used to resuspend the tissue pellet 
following the wash step.  Following culture, the remainder of the decontaminated 
tissue homogenates were divided into 0.5 ml aliquots and stored at –20oC.  Prior to 
dividing them a few drops from each homogenate was placed on a slide, heat killed at 
80
o
C for 90 min on a slide dryer and ZN stained as per section 2.5.  The slides were 
examined for the presence of AFB and the results recorded.  These results were used 
to classify the positive MTBC cultures into Low positive (no AFB visible on the 
slide), Medium positive (up to 2 fields with at least 1 AFB in each) and High positive 
(3 or more fields with at least 1 AFB in each).  There were 27 MTBC positive 
samples and 3 culture negative samples.   
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2.12 Dilution of Decontaminated Tissue Samples 
Tissue pellets were removed from the –20oC freezer and allowed to defrost 
overnight at 4
o
C.  A rough estimate of the size of the settled pellet was made using the 
graduation markings on the side of a 1.5 ml tube.  Each sample was diluted, in PBS, 
to a final pellet concentration of 50 μl of pellet per 500 μl of PBS. 
 
2.13 Heat Killing Procedure 
A water bath was preheated to 80 C and the sample e.g. tissue pellet or culture 
isolate, in a 1.5 ml tube, was submerged in the water for 60 min.  The tube was 
removed from the water and centrifuged at 15200 g for 10 min.  The supernatant was 
discarded and the pellet resuspended in 500 μl of PBS.  The sample was centrifuged at 
15200 g for 10 min and the supernatant discarded.  The pellet was frozen at –20oC 
until required for use.  The sample is now safe to be handled outside the category 3 
laboratory.  
 
2.14 Heat Lysis (HL) Procedure  
The heat-killed pellet, produced in section 2.13, was removed from the –20oC 
freezer and transferred to the PCR extraction lab.  The defrosted pellet was 
resuspended in 400 μl of UltraPure distilled water (Gibco, Cat #: 10977-035).  The 
sample was placed in a heating block, preheated to 100
o
C, and incubated for 15 min 
with periodic vortexing.  The sample was centrifuged at 5900 g for 1 min and the 
supernatant was transferred into a fresh 1.5 ml tube.  The pellet was discarded.  The 
supernatant collected was amplified as per section 2.23 and detected as per section 
2.25. 
 
2.15 Pre-treatment and Procedure for use of High Pure PCR Template 
Preparation Kit (HP kit) 
The samples were heat-killed, as described in section 2.13, and transferred to 
the PCR extraction lab.  The pellets were resuspended with 100 ml of 10 mg/ml 
lysozyme (Sigma, Cat #: L-7651), and incubated at 37
o
C for 2 hr with periodic 
mixing.  The tubes were centrifuged at 15200 g for 10 min and the supernatant was 
discarded.  Lysis Buffer, 200 l, (10mM Tris-HCl, 10mM EDTA, 1M GITC, 0.5M 
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NaCl, 2% Trition X-100, pH 8.5) was added to each sample and incubated, in a 
shaking waterbath heated to 37
o
C, overnight.   
Binding buffer (HP kit), 200 l, and 40 l of 20 mg/ml Proteinase K (Sigma, 
Cat #: P-2308) was added to each sample and incubated, in a shaking waterbath, for 
30 min at 72
o
C.  Isopropanol (Sigma, Cat #: I-9516), 100 l, was added to each tube 
and mixed well by pipette.  All the liquid mixture was transferred to the filter column 
in a filter tube/collection tube assembly and centrifuged at 5900 g for 60 sec.  The 
flow-through and the collection tube were discarded.   
The filter column was transferred to a fresh collection tube and 500 μl of 
Inhibitor Removal Buffer (HP kit) was added to the filter column.  The sample was 
centrifuged at 5900 g for 60 sec and the filter column was transferred to a fresh 
collection tube.  Wash Buffer (HP kit), 500 μl, was added to the column and the 
sample was centrifuged at 5900 g for 60 sec.  The filter column was transferred to a 
fresh collection tube and the Wash Buffer step was repeated twice.   
After the third wash buffer step the filter column was transferred to a fresh 
collection tube and centrifuged at 5900 g for 3 min to remove any residual wash 
buffer.  The filter column was transferred to a 1.5 ml micro-tube and 100 μl of Elution 
Buffer (HP kit), that had been pre-warmed to 70
o
C, was added to the filter column.  
The sample was centrifuged at 5900 g for 60 sec and the filter column was discarded.  
The collected liquid was amplified as per section 2.23 and detected as per section 
2.25. 
 
2.16 Pre-treatment and Modified Procedure for the High Pure PCR Template 
Preparation Kit  
The samples were heat-killed as described in section 2.13 and transferred to 
the PCR extraction lab.  The pellets were resuspended with 100 ml of 10 mg/ml 
lysozyme, and incubated at 37
o
C for 2 hr with periodic mixing.  The tubes were 
centrifuged at 15200 g for 10 min and the supernatant was discarded.  Each pellet was 
resuspended in 300 μl of Tissue Lysis Buffer (HP kit) and 60 μl of 20mg/ml 
Proteinase K and mixed well.  The samples were incubated at 55
o
C for 2 hr with 
periodic mixing.  Binding Buffer (HP kit), 300 μl, was added to each tube and 
vortexed for 20 sec.  The samples were incubated at 72
o
C for 30 min with vortexing 
of samples every 10 min.  The tubes were centrifuged at 5900 g for 5 min. The 
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supernatant, 540 μl, was transferred to a fresh tube and 100 μl of Isopropanol added.  
The samples were vortexed for 20 sec and the solution was transferred to the filter 
column in a filter tube/collection tube assembly.  The remainder of the DNA 
purification procedure was carried out as per section 2.15. 
 
2.17 Immunomagnetic Capture (IMS)  
A 0.1% Bovine Serum Albumin Buffer (BSA Buffer) was prepared by 
dissolving 0.5 g of Bovine Serum Albumin (Sigma, Cat No.: A7030) in 500 ml of 
sterile PBS and adjusting the pH to 7.4.  A volume of 25 μl of Dynabeads® Sheep-
anti Mouse IgG (Dynal, Cat #: 110-31) was used per sample tested.   
The required amount of Dynabeads was washed with BSA Buffer to remove 
preservatives, and resuspended, in the original volume, with BSA Buffer.  M. 
tuberculosis Mouse Monoclonal Antibody (Ab) (Vision Biosystems (Europe) Ltd., 
Cat #: NCL-MT), the antibody cross-reacts with all members of the MTBC, was 
added to the Dynabeads, 1 μl of Ab per 25 μl of Dynabeads, and incubated on a 
rotator (Stuart SB3 Variable Speed, Timed Rotator) for 24 hr at 2-8
o
C.   
The beads were washed after incubation to remove any unbound Ab from the 
beads.  The tube was placed in a magnetic separator for 1min and the supernatant was 
discarded.  The tube was removed from the magnetic separator and the pellet 
resuspended in 1.5 ml of BSA Buffer.  The wash step was repeated for a total of three 
times and after the final wash the pellet was resuspended in the original volume of 
beads used.   
The decontaminated pellets were removed from the –20oC freezer, defrosted 
and diluted as described in section 2.12.  After dilution the sample was centrifuged at 
15200 g for 10 min.  The supernatant was discarded and the pellet was resuspended in 
1 ml of BSA Buffer.  Antibody bound beads, 25 μl, were added to each sample and 
the tubes were incubated on the rotator for 30 min at 2-8
o
C.  BSA Buffer, 0.5 ml, was 
added to each sample and then the tubes were placed on the magnetic separator for 2 
min.  The supernatant was discarded and the pellet was resuspended in 1 ml of BSA 
Buffer.  A total of 3 washes were carried out and after the final wash the pellet was 
resuspended in 0.5 ml of PBS.  A schematic diagram of this procedure is shown in 
Figure 2.1 (Method adapted from Grant et al., 1998).  The samples were heat-killed, 
as per section 2.13, and heat-lysed, as per section  2.14. The samples were amplified 
as per section 2.23 and detected as per section 2.25.  
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Figure 2.1: Schematic Diagram of a Direct IMS procedure.  Adapted from Grant et al., 1998. 
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2.18 Bead Beating with a Hybaid Ribolyser Homogenizer 
Approximately 0.5 ml of 212-300 μm glass beads (Sigma, Cat #: G1277) were 
added to each decontaminated tissue sample.  The samples were placed in the 
Ribolyser, at speed 5, for 10 sec (A), 20 sec (B), 30 sec (C) and 40 sec (D).  After the 
bead-beating step the samples were transferred to fresh 1.5 ml tubes and care was 
taken to minimise the transfer of any glass beads.   
 
2.19 Limits of Detection of M. bovis on previously decontaminated tissue samples 
  A M. bovis stock solution was prepared as per section 2.6, using PBS.  To 
determine the cfu/ml count, 200 μl of each dilution was inoculated onto three 7H11 
plates.  Each plate was sealed with parafilm and incubated at 37
o
C for 28 days.  After 
incubation the colonies on each plate were counted and this was used to determine the 
cfu/ml as per equation below. 
Cfu/ml = average of plate colony count x 5 x 10 x dilution factor. 
A culture negative decontaminated lymph node sample, decontaminated as per 
section 2.11, was diluted as per section 2.12.  Aliquots, 0.5 ml, of the diluted culture 
negative sample were centrifuged at 15200 g for 10 min and the supernatant was 
discarded.  The pellets were resuspended in 0.5 ml of a dilution of the M. bovis stock.   
 
2.20 HAIN GenoType Mycobacterium Direct  
The kit version being evaluated was GenoType Mycobacteria Direct 4.0 (Hain 
Lifesciences, Cat #: H4010).  The test was carried out as per manufacturer‟s 
instruction and summarised below. 
The magnetic beads (MB - Hain kit) were mixed with the Binding Buffer 
(BIN – Hain kit) and added to the decontaminated tissue sample.  The sample was 
allowed to incubate at room temperature for 15 min.  Using a magnetic separator, the 
supernatant was discarded, and the MB resuspended in Lysis Buffer (LB – Hain kit) 
and incubated for 5 min at room temperature.  Absolute ethanol was added to each 
sample and incubated at room temperature for 5 min.  The sample was placed on the 
magnetic separator and the supernatant discarded.  The beads were resuspended in 
70% ethanol and vortexed.  The supernatant was separated from the beads by the use 
of the magnetic separator.  The beads were resuspended in a Bead Buffer (BB – Hain 
kit) that had the Internal Control RNA (ICR – Hain kit) added to it.  The sample was 
incubated at 85
o
C for 20 min and the supernatant was transferred to a fresh tube using 
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the magnetic separator.  The supernatant was mixed with the Primer Nucleotide Mix 
(PNM – Hain kit) and the Enzyme Mix Lyophilisate (EML – Hain kit), both pre-
prepared in a clean room, and a NASBA (Nucleic Acid Sequence Based 
Amplification) was carried out on the Twincubator® with amplification block (Hain 
Lifesciences, Cat #: 11620).   
The product from the NASBA reaction was bound to a membrane strip (Hain 
kit), which had specific probes bound to its surface, and detected with a colorimetric 
reaction.  The amplified product was denatured with a denaturation solution (X-DEN 
– Hain kit), in a well of a plastic tray (Hain kit).  Hybridisation buffer (HYB – Hain 
kit) was added to the sample and a membrane strip placed in the well.  The tray was 
incubated in the Twincubator® with hybridisation block (Hain Lifesciences, Cat #: 
11621) at 50
o
C for 30 min.  After incubation the buffer was discarded.  Stringent 
Wash Buffer (X-STR – Hain kit) was added to the strip and incubated for 15 min at 
50
o
C.  The X-STR was discarded. Conjugate buffer was added to the well and 
incubated for 30 min at room temperature.  After removing the buffer, the membrane 
strip was washed with 1 ml of Rinse Solution (X-RIN – Hain kit).  A second wash 
step with distilled water was carried out.  Substrate buffer was added to the membrane 
and incubated at room temperature until a banding pattern was seen on the strip or for 
a maximum incubation of 15 min.  The banding pattern was compared to the one 
supplied with the kit to determine the result. 
 
2.21 HAIN GenoType Mycobacterium Direct with enzymatic pre-treatment 
The decontaminated tissue samples were diluted as per section 2.12.  The 
samples where then centrifuged at 15200 g for 10 min and the supernatant was 
discarded.  The pellets were resuspended in 200 μl of BIN buffer (Hain kit) and 40 μl 
of Proteinase K (10 mg/ml) was added to each tube.  The samples were incubated 
overnight at 58
oC in a heating block.  The solution, 220 μl, was added to 30 μl of the 
MB/BIN mix. The kit procedure was then carried out as described in section 2.17 with 
the following modifications. 
The decontaminated tissue samples were diluted as per section 2.12.  To 
ensure that no magnetic beads remained in the sample tube after last magnetic bead 
separation each tube was centrifuged at 5900 g for 1 min.  The supernatant was 
transferred to a fresh tube and used in the amplification step and the pellet was 
discarded.  The PNM (primer nucleotide mix – Hain kit) was made up approximately 
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15 min prior to use within the TB Laboratory.  This was carried out in a BSC that was 
not used for any other molecular biology work.  The cabinet was suitably cleaned and 
treated with UV light prior to use.  Care was taken to ensure the EML (Enzyme Mix 
Lyophilisate - Hain kit) was prepared with gentle mixing only. 
 
2.22 Sequence Capture PCR method (adapted from Skuce et al., 2003) 
In a 1.5 ml tube, 0.5 ml of decontaminated tissue homogenate was added to 
0.5 ml of zirconia beads (Biospec Products, Inc, Cat No: 11079101z).  The tubes were 
spun down at 1520 0g for 10 min and the supernatant was discarded.  The beads and 
pellet were resuspended in 530 μl of TES buffer (100 mM Tris-HCl (pH7.4), 50 mM 
EDTA and 150 mM NaCl) and shaken in the bead beater for 45 sec at 6 m/s.  
Proteinase K, 20 μl at a concentration of 100 mg/ml, was added to each tube and 
incubated overnight at 55
o
C.   
The samples were shaken in a bead beater for 45 sec at 6 m/s.  The supernatant 
was transferred to a fresh tube and made up to 550 μl with TES buffer.  The samples 
were denatured by heating to 100
o
C for 7 min and cooling on ice for 5 min.   
A capture probe solution (2.5 pmol of each capture probe in 3.75 M NaCl), 
200 μl, was added to each sample and incubated at 42oC for 3 hr with gentle agitation.  
The magnetic beads (MB), Dynabeads® M-280 Streptavidin (Dynal, Cat No.: 
112.05D), were prepared as per manufacturer‟s instructions.  After capture probe 
incubation, 10 μl of the MB (5 mg/ml concentration) was added to each sample and 
incubated at 36
o
C for 2 hr with gentle agitation.   
After the second incubation the samples were placed on a MB separator for 3 
min and the supernatant was discarded.  The samples were removed from the MB 
separator and the beads were resuspended in 750 μl of wash buffer (10 mM Tris-HCl 
(pH 8.0) and 0.1 mM EDTA).  The samples were placed back on the MB separator for 
3 min and the supernatant was discarded.  The wash step was repeated twice more.  
After the finally wash, the beads were resuspended in 25 μl of UltraPure distilled 
water and stored at -20
o
C.  A schematic diagram for this procedure is shown in Figure 
2.2. 
Capture Probes (Biotinylated) (Skuce et al., 2003) 
   CapDR (5‟biotin-AAA AAG GTT TTG GGT CTG ACG AC-3‟) 
          CapDF (5‟biotin-AAA AAC CGA GAG GGG ACG GAA AC-3‟) 
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Figure 2.2: Schematic representation of a sequence capture PCR.  Adapted from 
Mangiapan et al., 1996. 
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The capture probes are specific for the DR region of MTBC.  The DR region 
is specific to the MTBC and consists of a variable number of two types of short 
sequences, DR sequences, which are identical and spacers, which are all unique.  
Different isolates can be identified by the presence / absence of one of more spacers 
(Butcher, 1996; Haddad et al., 2004).  
 
2.23 DNA amplification: Primer MSP 1/2 
A PCR master mix, 40 μl, was made up in a clean room as follows: 5 μl of 10 
x PCR Buffer, 2.5 μl of 25 mM MgCl2, 2.5 μl of 10 mM dNTPs (Sigma, Cat #: 
DNTP-100), 0.25 μl of Jumpstart TAQ DNA Polymerase (Sigma, Cat #: D4184), 0.2 
μl of MSP 1/2 (Mycobacteria Species Primer) primer mix and 29.55 μl of UltraPure 
Distilled Water. 
The extracted DNA, 10 μl, was added to each 40 μl PCR mix in the PCR 
extraction laboratory, with each sample tested in duplicate.  The mix was transferred 
to the PCR detection laboratory and amplified on thermocycler (Techne Flexigene) 
with heated lid, preheated to 105
o
C.  The program used was 1 cycle of 95
o
C for 1 min, 
35 cycles of 95
o
C for 30 sec, 50
o
C for 40 sec and 72
o
C for 40 sec, 1 cycle of 72
o
C for 
10 min and hold at 4
o
C.   
MSP 1/2 Primer (Roth et al., 2000) 
 Primer 1 (5‟-ACC TCC TTT CTA AGG AGC ACC-3‟) 
 Primer 2 (5‟-GAT GCT CGC AAC CAC TAT CCA-3‟)    
This primer targets part of the 16S-23S ribosomal DNA (rDNA) internal 
transcribed spacer and is specific to mycobacteria.  
 
2.24 DNA Amplification: Primer Cap F/R 
A PCR master mix, 45 μl, with Q solution, was made up in a clean room as 
follows: 5 μl of 10 x PCR buffer (containing 15 mM MgCl2) 1μl of 10 mM dNTP, 10 
μl of Q solution, 0.25 μl Hotstar TAQ DNA Polymerase (Qiagen, Cat #: 203205), 0.4 
μl of CAP F/R primer mix and 28.35 μl of UltraPure Distilled Water. 
A PCR master mix, 45 μl, without Q solution was made up in a clean room as 
follows: 5 μl of 10 x PCR buffer (containing 15mM MgCl2) 1 μl of 10mM dNTP, 10 
μl of Q solution, 0.25 μl Hotstar TAQ DNA Polymerase, 0.4 μl of CAP F/R primer 
mix and 38.35 μl of UltraPure Distilled Water.  
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The extracted DNA, 5 μl, was added to each 45 μl PCR mix in the PCR 
extraction laboratory, each sample was tested in duplicate.  The mix was transferred 
to the PCR detection laboratory and amplified on thermocycler with heated lid, 
preheated to 105
o
C.  The program used was 1 cycle of 95
o
C for 15 min, 35 cycles of 
94
o
C for 40 sec, 68
o
C for 60 sec and 72
o
c for 60 sec and 1 cycle of 72
o
C for 7 min. 
Cap F/R Primer (Skuce et al., 2003) 
 Cap F (5‟-AAA AAC GAA CGG CTG ATG ACC AAA CTC-3‟) 
 Cap R (5‟-AAA AAG GAG GTG GCC ATC GTG GAA G-3‟)    
 
2.25 Analysis of PCR Product 
An agarose gel was made by dissolving 1.5 g of agarose (Sigma, Cat 
#.:A9539) and 10 μl of SYBR Safe DNA gel stain (Invitrogen, Cat #: S33102) per 
100 ml of 1 x TAE (40 mM Tris-acetate and 1 mM EDTA, pH 8.3) Buffer (Sigma, 
Cat #:T8280).  The amplified sample was prepared for loading onto the gel by mixing 
10 μl of the amplified sample with 2 μl of gel loading buffer (Sigma, Cat #: G7654).  
A 50 bp DNA ladder (BioLabs, Cat #: N3236S) was prepared by mixing 1 μl of DNA 
ladder with 9 μl of water and 2 μl of gel loading buffer. Each well on the gel was 
loaded with 10 μl of sample mixture.  The gel was run at 100 volts for 2 hr with a 
Power pack (Bio Rad Power Pack Basic).  The gel was photographed, under UV light, 
by a FluorChem SP (Alpha Innotech). 
 
2.26 Statistical Analysis 
Statistical analysis, using the chi square test, was done to perform a pair-wise 
comparison of the isolate recovery rates, contamination rates and time to detection for 
the different culture systems.  Comparisons with a P value of <0.01 were considered 
significant.  This was carried out using an online program available at 
http://graphpad.com/quickcalcs/chisquared1.cfm.   
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Chapter 3. 
 
 
Development of Culture Methods for the Detection of 
M. bovis in Lymph Node Tissue. 
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3.1 Introduction 
The BACTEC 460 is a semi–automated liquid culture system that has evolved 
to become the “gold standard” to which other systems are compared (Zuhre Badak et 
al., 1996).  The system has many limitations including the handling, storage and 
disposal of radioactive material and labour requirements related to the loading and 
unloading of sample bottles from the incubator to a semi-automated instrument, 
Figure 1.10, for growth monitoring. Other drawbacks include the risk of needle stick 
injury, needles are used to inoculate and remove material from the culture bottles, 
Figure 3.1, and an incompatibility with modern data handling systems (Zuhre Badak 
et al., 1996; Scarparo et al., 2002). 
The MGIT 960 is a liquid culture system that addresses these limitations. It is 
a fully automated system, Figure 1.11, which continuously monitors growth in the 
tubes, has a high capacity, is non-radiometric and non-invasive (Kanchana et al., 
2000).  The MGIT 960 liquid culture system has been shown, in previous studies, to 
perform well for the isolation of MTBC, from human clinical samples, when 
compared to BACTEC 460 and solid media (Kanchana et al., 2000; Zuhre Badak et 
al., 1996; Scarparo et al., 2002).  It was of limited use in veterinary laboratories due 
to its poor growth of MTBC from bovine lymph node tissue samples (Yearsley et al., 
2000).  The manufacturer altered the media formulation to improve this and a study in 
Iowa has shown that the MGIT 960 system can now support the growth of M. bovis 
from bovine lymph node tissues (Hines et al., 2006).  
Decontamination with OA is the preferred method, within the CVRL, for 
preparation of lymph node tissue for MTBC culture.  CPC is not recommended by the 
manufacture for use with the MGIT 960 liquid culture system (Siddiqi and Rüsch-
Gerdes, 2006) but it is used to decontaminate badger tissues for MTBC culture as part 
of the Badger Vaccine Project.  This is a research project run by UCD, with funding 
supplied by the Department of Agriculture and Food, with the aim of developing a 
vaccine to control TB in badgers and remove a potential source of TB transmission to 
cattle (Gormley and Corner, 2011). A comparison was carried out between OA and 
CPC to determine if any difference between the performances of the two 
decontamination protocols, using MGIT 960 as the liquid culture system, could be 
noted.  
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Figure 3.1 BACTEC 460 bottle showing rubber septum used to inoculate the bottle 
(Costello, 2004). 
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3.2 Results 
3.2.1 Limits of Detection for M. bovis in Liquid Culture 
The primary aim of this work was to determine if the MGIT 960 liquid culture 
system could support M. bovis growth and to determine if the limits of detection for 
culture of M. bovis, with the MGIT 960, are similar to those for the BACTEC 460.  
The procedure was set up as described in section 2.7. 
The negative lymph node tissue needed to be decontaminated prior to culture, 
to prevent growth of contaminating bacteria, but the M. bovis stock could have been 
added after this step.  The decision was made to spike the M. bovis dilutions into the 
tissues prior to decontamination to keep the conditions as similar as possible to that of 
routine culture. 
The growth on the 7H11 plates was recorded after 28 days of incubation when 
the colonies were counted.  The colonies of M. bovis are circular with an undulating 
periphery, white/cream in colour and elevated in the middle, Figure 1.9.  The only 
dilution that gave a useable count was the 1 x 10
-3
 dilution.  The average colony count 
on the 3 plates was 50.33 colonies.  Using the equation to determine the cfu/ml, 
described in section 2.7, the starting concentration of M. bovis was determined to be 
2.5 x 10
6 
cfu/ml. 
M. bovis growth was indicated in both MGIT 960 tubes and BACTEC 460 
bottles down to the 1 x 10
-4
 dilution with cording, as shown in Figure 1.2, being seen 
in each ZN stain.  Cording was detected in two BACTEC 460 bottles and three MGIT 
960 tubes at the 1 x 10
-5
 dilution while only one MGIT 960 tube showed cording at 
the 1 x 10
-6
 dilution.  No growth was detected in the remaining dilutions or the 
negative control after 7 weeks of incubation.   
From Figure 3.2 it can be seen that both liquid culture systems showed similar 
results and were able to detect growth in all tubes down to 2.5 x 10
2
 cfu/ml.  The time 
to detection of growth for the first four dilutions (1 x 10
-1
 – 1 x 10-4) was 7.42 days for 
BACTEC and 7.36 days for MGIT.  The dilutions lower than 2.5 x 10
2 
cfu/ml were 
excluded from the calculation of the average time to growth detection since not all 
media tubes showed growth. 
These results show that the MGIT 960 system is capable of supporting M. 
bovis growth.   
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Figure 3.2:  Time to detection of cording at each dilution by the BACTEC 460 
(BACTEC) and MGIT 960 (MGIT) liquid culture systems.  The number in each 
column indicates the number of media, for each system, that showed cording. 
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3.2.2 Comparison of Different Culture Systems for MTBC Growth from LN 
Tissues 
Having determined that the MGIT 960 system can support the growth of M. 
bovis, the two liquid culture systems, MGIT 960 and BACTEC 460, and solid culture 
media (1 LJP and 1 Stonebrinks medium) were compared for the detection of 
Mycobacteria in routine lymph node (LN) samples. 
Decontamination of 867 routine LN samples, submitted to the CVRL for TB 
culture, from bovine and a small number of samples other species, specifically 51 
badgers, 10 cervine, 19 ovine and miscellaneous animal species (4 Alpaca, 2 Porcine, 
1 Canine and 1 Caprine), was carried out as described in section 2.1.  After a liquid 
culture media flagged positive and had AFB been seen on a ZN stain, section 2.5, the 
sample was sub-cultured, section 2.8, and identified using GenProbe Accuprobe kits, 
section 2.9. 
From the 867 lymph node tissues cultured the number of isolates identified is 
shown in Table 3.1.   
Both liquid culture systems performed better than or as well as solid culture 
system over all isolates identified.  Figure 3.3, shows a breakdown of the number of 
isolates identified by the two liquid culture systems, MGIT 960 and BACTEC 460 
and by the solid culture system (LJP and Stonebrinks Mediums).  Both liquid culture 
systems gave similar results for the isolation of MTBC but neither identified all 
MTBC positive tissues (92% for BACTEC and 93.2% for MGIT).  A pair-wise 
comparison, section 2.26, of the MTBC recovery rates between each of the different 
culture system is shown in Table 3.2.  There is no statistically significant difference 
between the two liquid culture systems however there is a statistically significant 
difference between each of the liquid cultures systems and solid media.   
There appears to be a difference for the isolation of atypical mycobacteria 
between the liquid culture systems (Figure 3.3) but due to the low number of isolates 
detected, 19 isolates, it was not possible to carry out statistical analysis. The MGIT 
960 system isolated only 9 of the atypical mycobacteria and the BACTEC 460 system 
isolated 17 isolates.  This agrees with the findings of previously published reports 
(Kanchana et al., 2000; Zuhre Badak et al., 1996; Scarparo, et al., 2002).  No further 
work was carried out to identify which isolates the MGIT media supported and which 
were unable to grow.  Each culture system should be able to support the growth of as  
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Table 3.1: Total number of Tissue Samples from which isolates were identified.  
Atypical mycobacteria are mycobacteria that are not part of the MTBC group or M. 
avium.   
 
 
 
 
 
 
 
 
 
Figure 3.3:  The difference in the number of isolates with each of the different culture 
systems. 
 
 
Table 3.2: Pair-wise comparison of the 3 culture systems for the difference in the 
recovery rate of MTBC 
Systems compared Percent Difference P-Value 
MGIT versus BACTEC 1.1 >0.58 
MGIT versus Solid Media 18.8 <0.01* 
BACTEC versus Solid Media 17.7 <0.01* 
* Statistical significant difference (P<0.01) between the 2 media 
systems 
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many species of mycobacteria as possible but atypical mycobacteria have no clinical 
significance to the eradication of bovine TB. 
The number of M. avium isolates was very low at a total of 6 isolates.  The 
MGIT system identified all of these and the other culture systems identified only 2 
isolates each. 
Due to the cell wall structure of Rhodococcus equi, it is resistant to 
decontamination with 5% oxalic acid and is isolated during TB culture.  R. equi is 
distinguished from mycobacteria by the presence of coccobacilli, which are usually 
non-acid-fast, on a ZN stain, the growth of salmon pink colonies, Figure 1.8, on a 
blood agar plate and the colony morphology on solid media, Figure 1.14.  The liquid 
medium used in the MGIT system seems better able to support the growth of R. equi 
than either BACTEC or solids (Percentage of R. equi isolated: 96.6% with MGIT, 
79.5% with BACTEC and 42% with solids).  Statistical analysis, section 2.26, shows 
that there is a significant difference between all three culture systems for the isolation 
of R. equi, Table 3.3. Use of the MGIT system routinely will increase the number of 
R. equi isolates from samples. 
No individual culture system can identify all isolates and to increase the 
effectiveness of the culture procedure a combination of solid and liquid culture is 
used.  When each liquid culture system was combined with solid culture, Figure 3.4, 
the isolation of MTBC (96.6% for BACTEC and solids and 98.3% for MGIT and 
solids) and other isolates was improved. 
Most of the MTBC isolates are identified in the first 3 weeks of culture with 
both liquid culture systems (81.1% on BACTEC and 78.9% on MGIT).  The MGIT 
960 system detects growth of MTBC, on average, slightly faster than the BACTEC 
460 system (14.5 days (range 1-49 days) on MGIT to 15.2 days (range 2-49 days) on 
BACTEC), shown in Figure 3.5, but both liquid culture systems detect MTBC growth 
faster than solid culture systems which take an average of 25.6 days (range 10–49 
days).  A pair-wise comparison of the time to detection for MTBC growth, section 
2.26, indicates that there is no statistically significant difference between the liquid 
culture systems but there is a difference between each of the liquid culture systems 
and solid culture, Table 3.4.  MGIT 960 also shows faster growth for atypical 
mycobacteria and R. equi isolates.  This is probably due to the continuous monitoring 
of the tubes in the MGIT 960 instrument whereas the BACTEC 460 bottles are 
monitored on a schedule. 
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Table 3.3: Pair-wise comparison of the 3 culture systems for the difference in the 
recovery rate of R. equi 
Systems compared Percent Difference P-Value 
MGIT versus BACTEC 17.1 <0.01* 
MGIT versus Solid Media 54.6 <0.01* 
BACTEC versus Solid Media 37.5 <0.01* 
* Statistical significant difference (P<0.01) between the 2 media 
systems 
 
 
 
Figure 3.4: The number of isolates for each of the liquid culture systems when 
combined with solid culture. 
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Figure 3.5:  The average length of time to growth detection in both the MGIT 960 and 
BACTEC 460 liquid culture systems.  The numbers in the columns indicate the 
number of samples the average is taken over. 
 
 
 
Table 3.4: Pair-wise comparison of the time to detection of MTBC between the 
different culture systems 
Systems compared Difference in Days P-Value 
MGIT < BACTEC 0.6 >0.79 
MGIT < Solid Media 11 <0.01* 
BACTEC < Solid Media 10.4 <0.01* 
* Statistical significant difference (P<0.01) between the 2 media 
systems 
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The contamination rate for the MGIT 960 system was close to three times 
greater than the BACTEC 460 system, at 8.2% for the MGIT system and 3.1% for the 
BACTEC system.  While not ideal, this is within the acceptable contamination rate of 
between 2-10% (Collins et al., 1997).  Routine use of the MGIT system may cause an 
increase in the number of samples that have contamination and will require 
reprocessing.  For solid culture systems the contamination rate was higher than both 
liquid culture systems and outside the acceptable range, at 10.9%.  The solid culture 
systems do not benefit from the addition of the PANTA antibiotic mixture, prior to 
sample inoculation, like both liquid culture systems. Table 3.5 shows that there is a 
statistically significant difference between the contamination rates in all three culture 
systems when pair-wise comparison, section 2.26, was carried out. 
 
3.2.3 Decontamination Study 
Having shown the ability of the MGIT 960 liquid culture system to support the 
growth of M. bovis, from routine lymph node tissues, a comparison was carried 
between two different decontamination protocols.   The comparison was carried out 
with 5% OA, the preferred decontamination method within the CVRL, and with 
0.75% CPC, the decontamination method used as part of the badger project, for 
decontamination of lymph node tissues prior to culture. 
Decontamination of 144 routine bovine lymph node samples was carried out 
with OA, section 2.2, and CPC, section 2.10.  After a tube flagged positive and had 
AFB seen on a ZN stain, section 2.5, the sample was sub-cultured, section 2.8, and 
identified using GenProbe Accuprobe kits, section 2.9. 
Table 3.6, shows the total number of isolates identified with a combination of 
liquid and solid culture for both decontamination protocols.  The two atypical 
mycobacteria isolated grew on the CPC decontaminated solid media one of which was 
also isolated from an OA decontaminated MGIT tube. 
The breakdown on the number of MTBC and R. equi isolates on solid and 
liquid culture, with each decontamination protocol, is summarised in the following 
series of Tables 3.7 and 3.8 and Figures 3.6 and 3.7.  The difference between the two 
decontamination methods is more pronounced in the MGIT 960 liquid culture system 
than with solid culture.  Statistical analysis could not be carried out due to the small 
number of isolates.  All MTBC isolates are identified with OA decontamination but 
this method identified only 8 of a total of 13 R. equi isolates.   
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Table 3.5: Pair-wise comparison of the contamination rates for the 3 culture systems  
Systems compared Percent Difference P-Value 
MGIT > BACTEC 5.1 <0.01* 
MGIT < Solid Media 2.7 <0.01* 
BACTEC < Solid Media 7.8 <0.01* 
* Statistical significant difference (P<0.01) between the 2 media 
systems 
 
 
 
Table 3.6:  Total numbers for each isolate on a combination of liquid and solid culture 
with each decontamination method. 
 
 
 
 
 
 
 
Table 3.7: The number of MTBC isolates with each decontamination method. 
 
 
 
 
 
 
Table 3.8: The number of R. equi isolates with each decontamination method. 
 
 
 
Liquid and Solid Media Combined 
  OA  CPC  Total  
MTBC 19 9 19 
Atypical 1 2 2 
R.equi 8 11 13 
MTBC Isolates (total = 19) 
  MGIT Solid Total # Isolated 
5% OA 17 12 19 
0.75% CPC 1 9 9 
R. equi Isolates (total = 13) 
  MGIT Solid Total # Isolated 
5% OA 8 2 8 
0.75% CPC 0 11 11 
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Figure 3.6: A comparison of the number of MTBC isolates, on MGIT 960 liquid 
culture system and solid culture system, with each decontamination method. 
 
 
 
 
Figure 3.7: A comparison of the number of R. equi isolates with each decontamination 
method. 
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CPC decontamination has clearly been shown to be not suitable for use with 
MGIT 960 liquid culture system, Tables 3.3 and 3.4 and Figures 3.7 and 3.8.  
However, this decontamination method performed much better than OA 
decontamination for the detection of R. equi infection and identified both atypical 
mycobacteria isolates with solid culture, Table 3.4 and Figure 3.8.  Neither of these 
isolate types are vital results since the main aim of culture was to identify a MTBC 
infection.  However, if further study was ever carried out on either of these isolate 
types the possibility of using CPC decontamination, on solid culture only, should be 
borne in mind.   
In this study, the contamination rate was 4.86% for Oxalic acid and 1.39% for 
CPC in MGIT liquid culture.   In the solid culture system the rate of contamination 
was much higher with 10.42% for oxalic acid and 18.75% for CPC.  As stated 
previously, a contamination rate of between 2 and 10% is acceptable depending on 
several conditions such as sample type, age and storage conditions (Collins et al., 
1997). A difference in contamination rates between liquid and solid culture has to be 
expected since the MGIT liquid culture media is supplemented with an antibiotic mix, 
PANTA, prior to inoculation with the decontaminated samples.  This mix would aid 
in the suppression of growth of contaminating bacteria.  The solid media have no such 
antibiotic mix added and are dependent upon the effectiveness of the decontamination 
protocol to ensure the level of contamination is kept to a minimum.   
For OA decontamination the contamination rate is close to the acceptable 
range, with 4.86% for MGIT media and 10.42% for solid media.  The MGIT media 
contamination rate is lower than that shown above, in the comparison between the 
BACTEC 460 and MGIT 960 liquid culture systems, of 8.2% for MGIT 960.  This 
difference is probably due to the sample conditions. 
For CPC decontamination the contamination rate is outside the acceptable 
range, with a rate of 18.75% for solid media, and 1.39% for MGIT media.  This 
extreme difference between the solid and liquid culture may be caused by the dilution 
of any remaining CPC in the sample, following the decontamination procedure, in the 
liquid culture media.  For CPC the Critical Micellar Concentration (CMC) is 0.32%.  
At this concentration the molecules of the detergent form small monomers which 
appear to be toxic since they are small enough to pass though the bacterial cell wall.  
At a concentration above 0.32% the molecules form micelles which are too large to 
pass though the bacterial cell wall (Brown et. al., 2005).  This would not affect solid 
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media since any excess decontaminant would be absorbed by the media before the 
CMC would be reached. 
 
3.3 Discussion  
Over time it had become necessary to find a replacement for the BACTEC 460 
liquid culture system due to its safety concerns and lack of data handling system.  The 
MGIT 960 liquid culture system had many advantages over the BACTEC 460 system 
however a previously published report by Yearsley et al. had indicated the MGIT 960 
system could not support the growth of M. bovis from bovine LN tissue (Yearsley et 
al., 2000).  The MGIT media had been modified, since that work was carried out, to 
allow the culture system to support M. bovis growth.   The success of the change to 
the media formulation was shown by the results of limits of detection study for M. 
bovis, after being spiked into TB negative LN tissue, since both MGIT 960 and 
BACTEC 460 liquid culture systems gave the same result at 2.5 x 10
2
cfu/ml, section 
3.2.1.    
While this result was promising it was not sufficient to allow the MGIT 960 
system to replace the BACTEC 460 system, the current “gold-standard” for TB 
culture (Zuhre Badak et al., 1996).  A total of 867 routine lymph node tissues were 
cultured on both liquid culture systems and solid culture system.  For the detection of 
MTBC isolates the results from the MGIT 960 system were comparable to that of the 
BACTEC 460 system, 93.1% on MGIT and 92% on BACTEC, and both liquid 
culture systems preformed better that solid culture system, which detected 73.9% of 
MTBC isolates.  The MGIT 960 system detected growth of MTBC isolates slightly 
faster than the BACTEC 460 system with average days to detection of 14.6 days for 
MGIT compared to 15.2 days for BACTEC which was probably due to the continuous 
monitoring of the cultures in the MGIT 960 instrument compared the schedule used to 
monitor the BACTEC bottles.   
Previously published work that compared both BACTEC 460 and MGIT 960 
for the culture of mycobacteria from humans all showed broadly similar results to this 
study for MTBC detection, even though differing decontamination protocols were 
used (Chew et al., 1998; Scarparo et al., 2002; Kanchana et al., 2000; Hanna et al., 
1999; Somoskövi et al., 2000; Tortoli et al., 1999; Zuhre Badak et al., 1996).  These 
studies had been carried out primarily on respiratory samples with most including less 
than 10% of extra-pulmonary sample types.  A single article, Chew et al. included 
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over a third of the samples from LN tissues but it was not stated how many of the LN 
samples were positive for mycobacterial growth (Chew et al., 1998).   
A study from Iowa compared the MGIT 960, BACTEC 460 and solid media 
(7H10 and 7H11) for TB culture of bovine LN tissues, using the N-acetyl-L-cysteine 
sodium hydroxide (NALC-NaOH) decontamination method (Hines et al., 2006).  
They reported a M. bovis detection rate of 94.6% for the MGIT 960 system and 74.4% 
for the solid culture system which, even though a different decontamination method 
and different solid culture systems were used, was similar to the MTBC detection rate 
in this study of 93.1% for MGIT 960 and 73.9% for solid culture systems.  A 
difference in the results was seen for the BACTEC 460 system which detected only 
79.1% of M. bovis isolates in Hines et al. compared to a MTBC detection rate of 92% 
here.  This was an unusual result since the results from human studies had put the 
MTBC detection rate for BACTEC 460 system very similar to MGIT 960 system 
(Chew et al., 1998; Scarparo et al., 2002; Kanchana et al., 2000; Hanna et al., 1999; 
Somoskövi et al., 2000; Tortoli et al., 1999; Zuhre Badak et al., 1996).  The days to 
detection was also much longer in Hines et al., 2006 report for the BACTEC 460 
system at 28.2 days with 15.8 days reported for the MGIT 960 system.   
The decontamination method is unlikely to be the reason for the differing 
results with BACTEC 460 system since the results from the MGIT 960 system were 
so similar.  A possible explanation may that in this study the result is based on growth 
of MTBC isolates compared to M. bovis isolates in the Hines et al., 2006 study since 
due to limited resources further testing was not done on the routine culture MTBC 
isolates to identify the isolate species.  Another explanation is the differing criteria 
when the time to detection result was recorded in the Hines et al., 2006 study the time 
to detection was noted when the BACTEC bottle gave a GI reading of 300 compared 
to a GI reading of 50 in the work reported here.  Culture procedure was altered for 
BACTEC 460 system in Hines et al., 2006 compared to this study, with erythromycin, 
at a concentration of 32 µg/ml per BACTEC bottle, being added to the PANTA 
antibiotic mixture.  It was not known how this could affect the M. bovis detection rate 
with the BACTEC 460 system since this antibiotic had been shown to have no 
inhibitory effect on M. bovis but it may have reduced the concentration of growth 
promoter, POES, in the BACTEC bottle (Demoulin et al., 1983).   
For the detection of atypical mycobacteria or M. avium isolates it is difficult to 
draw conclusions from the results since the total number of isolates, 25 non-
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tuberculosis mycobacteria (NTM), identified by the different culture systems was 
small, Figure 3.5.  For M. avium the MGIT 960 system, which identified a total of 6 
isolates, performed better than both the BACTEC 460 system and solid culture 
systems, which only identified 2 isolates each.  However, for the detection of atypical 
mycobacteria the MGIT 960 system, which identified a total of 9 isolates, had a 
poorer performance that the BACTEC 460 system, which identified 17 isolates.  Solid 
culture systems only identified 2 atypical mycobacteria isolates.  No work was carried 
out to identify which NTM could be supported by the MGIT 960 system and which 
NTM species failed to grow.  The lower detection rate for NTM with the MGIT 960 
system does agree with the finding of some previously published reports on human 
clinical samples (Zuhre Badak et al., 1996; Kanchana et al., 2000; Scarparo et al., 
2002).  With human TB cases NTM are of clinical significance, particularly in 
immune-compromised patients, however diagnosis of these infections, which could 
provide information to improve animal health and husbandry, are not critical for the 
Bovine TB Eradication Scheme.   
The contamination rate for the MGIT 960 system was nearly three times great 
than the BACTEC 460 system, at 8.2% for the MGIT system compared to 3.1% for 
the BACTEC system, but both had a lower contamination rate that the 10.9% for solid 
culture systems.  The MGIT media is more nutrient rich than the BACTEC media. 
The BACTEC media only provides C
14
-labelled palmitic acid and most bacteria 
cannot utilize this fatty acid so will not grow under these conditions (Hines et al., 
2006).  The higher contamination rate with the solid culture systems was probably due 
to its dependence on the effectiveness of the decontamination protocol since both 
liquid culture systems benefited from addition of an antibiotic cocktail prior to sample 
inoculation.  The higher contamination rate with the MGIT 960 system, compared to 
the BACTEC 460 system, had been reported previously though the rate of 
contamination differs depending on the sample type and decontamination method 
used (Scarparo et al., 2002; Kanchana et al., 2000; Hanna et al., 1999; Somoskövi et 
al., 2000; Hines et al., 2006) 
The MGIT 960 system supports the growth of R. equi much better that 
BACTEC 460 and solid culture systems, 96.6% for the MGIT system compared to 
78.4% for BACTEC system and 40.9% for solid culture systems.  There nothing in 
the published literature about the isolation of R. equi during TB culture from 
veterinary samples and it is likely that this bacterium is classed as contaminant in 
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other studies.  R. equi diagnosis is an important result, since a R. equi infection causes 
a granuloma in lymph nodes tissue that would be visually similar to a TB granuloma 
and detected during abattoir meat inspections.   
This study also evaluated the suitability of 0.75% CPC as a decontaminant for 
the culture of MTBC from LN tissues for use with the MGIT 960 and has shown that 
it is not a suitable chemical for this purpose, Figure 3.8 and Table 3.3.  This result 
agrees with the manufacturer‟s recommendations and with Brown et al. and 
McLernon et al. had both shown that CPC decontamination was not suitable for use 
with BACTEC 460 liquid media (McLernon et al., 2004; Brown et al., 2005; Siddiqi 
and Rüsch-Gerdes, 2006).  Corner et al. had shown that on balance CPC was most 
suitable chemical for the decontamination of tissues prior to M. bovis culture on solid 
media (Corner et al. 1995).   The results from this study disagree with that, since even 
though solid culture systems identified more MTBC isolates than the MGIT 960 
system with CPC decontamination, OA decontamination detected more MTBC 
isolates on both liquid and solid culture systems, Figure 3.8.    
For the isolation of R. equi, use of CPC decontamination coupled with solid 
culture systems only, would enhance the number of isolates detected, Figure 3.9.  This 
could be useful if further research was undertaken on R. equi infections in cattle.  The 
low number of atypical mycobacteria identified in this study, 2 isolates, means that it 
is difficult to draw any conclusions from this result.    
 
3.4 Conclusion 
This study has provided more evidence on the suitability of the MGIT 960 
system as a replacement for the BACTEC 460 system for the culture of MTBC from 
veterinary LN tissue.  No single culture system identified all isolates and even when 
each liquid culture system was combined with solid culture system (LJP and 
Stonebrinks) not all isolates were identified, Figure 3.6.  The use of all three systems, 
MGIT 960, BACTEC 460 and solid culture, together continually, would allow for the 
maximum number of isolates but would increase the workload and the cost, since the 
liquid culture systems are expensive to maintain.  A compromise has to be made 
between the maximum number of isolates, cost, ease of use and safety concerns.  
Identification and confirmation of MTBC infected tissues is of the primary 
significance for the Bovine TB Eradication Scheme.  While detection of atypical 
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mycobacterium and M. avium infections are important they are not critical for the 
reduction and potential elimination of M. bovis from the bovine population.  
This study had shown that both the liquid culture systems performed equally 
well for the detection of MTBC infected tissues and that the MGIT 960 system is a 
suitable replacement for the BACTEC 460 system.  The use of the MGIT 960 system 
in place of the BACTEC 460 system will involve compromise.  These include the 
reduction in the detection of atypical mycobacteria infections, increased number of R. 
equi isolates being grown in culture and a possible increase in the number of cultures 
that require treatment for contamination.  These are balanced out by a reduction in 
safety concerns, due to the elimination of needles and radioactive material, C
14
, from 
the culture procedure, a reduction in labour requirements and a reduced time to 
detection of MTBC, due to the automated monitoring system.  On balance, the 
advantages offered by the MGIT 960 system over the BACTEC 460 system outweigh 
the disadvantages. 
As recommended, the use of CPC does not appear to be a suitable 
decontamination method for tissues prior to MTBC culture when coupled with the use 
of the MGIT 960 liquid culture system.  It should be considered if further study was 
to be carried out on R. equi infections in cattle but only for use with solid media. 
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Chapter 4.  
 
 
Evaluation of Different Molecular Methods for the 
Direct Detection of M. bovis in Lymph Node Tissue. 
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4.1 Introduction 
For the majority of suspect Bovine tissue lesions received in the TB 
Laboratory, a diagnosis can be made based on histopathological examination within 
one week. However, it is not possible to make a diagnosis based on histopathology in 
all cases and these samples must be cultured. 
Culture of tissue samples for isolation of MTBC can take up to 7 weeks or 
longer, during which time the TB status of the herd is undetermined.  For the majority 
of herd owners this delay is not problematic but for a small number, such as Singleton 
Reactor herds, it may cause significant inconvenience.  Annual testing to determine 
the TB status of cattle herds is done using the Single Intradermal Comparative 
Tuberculin Test (SICTT).  Approximately a third of the herds, which disclose reactors 
to this test, have only one animal giving a positive reaction.  Because the tuberculin 
test is not 100% specific it is possible that some of these are false positive reactions. If 
epidemiological criteria suggest this possibility and no visible lesions are detected 
during a post slaughter examination of the carcass, then, LN tissue samples are 
obtained for culture. These samples are submitted to the TB Laboratory as Singleton 
Reactors.  Samples from approximately 600 Singleton Reactors are examined at the 
CVRL each year, most of which are culture negative (Good and Duignan, 2011). 
A direct detection test, which could provide a result in a few days, would be of 
great benefit both for singleton reactors and samples from animals that are linked to a 
suspected human TB infection i.e. pets.  PCR based direct detection tests are used for 
the detection of mycobacteria in human sputum samples but so far have had only 
limited application for the detection of mycobacteria in animal tissue samples. There 
have been difficulties in regard to samples with low numbers of organisms, problems 
in extracting and harvesting DNA or RNA from mycobacteria and also problems with 
PCR inhibitors within tissues (Mangiapan et al., 1996; Roring et al., 2002).  
For this study five different methods were used to isolate and detect MTBC 
DNA from decontaminated lymph node (LN) tissue samples.  These were heat lysis, 
High Pure PCR Template Preparation Kit (Roche Applied Science, Cat #: 
11796828001), Immunomagnetic Separation (IMS), GenoType Mycobacteria Direct 
4.0 (GTMD) (Hain Lifesciences, GMBH, Nehren Germany, Cat #: H4010) and 
Sequence Capture PCR.   
A total of 30 samples were used for each method, made up of 27 MTBC 
culture positive and 3 culture negative tissues.  The MTBC positive tissues were 
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classed as high, medium to low positives, based on a direct ZN examination of the 
decontaminated tissue homogenate prior to inoculation into the culture media and 
storage (this is described in more detail in section 2.11). 
 
4.1.1 Heat Lysis  
The first method evaluated was heat lysis (HL), of a heat killed 
decontaminated tissue sample.  This was selected since it is a simple and effective 
method for releasing DNA from cells and it was the method used to extract the M. 
bovis DNA, used as the PCR positive control, from a culture.  Centrifugation of the 
sample, after heat lysis, is the only method of purification of the released DNA from 
the cell debris and any other contaminating molecules within the sample.   
 
4.1.2 High Pure PCR Template Preparation Kit (High Pure Kit) 
The second method evaluated was the High Pure PCR Template Preparation 
Kit (Roche Applied Science, Cat #: 11796828001) which is designed to purify nucleic 
acids from other contaminating molecules.  To do this, the kit uses a combination of 
chemical and enzymatic digestion to lyse cells and inactivate any nucleases present in 
a sample.  Absorption chromatography is then used for nucleic acid purification. 
Lysozyme and a tissue lysis buffer weaken the cell walls.  A Proteinase K 
digestion breaks open the cell membranes and chaotropic salt (guanidine HCl), in the 
binding buffer, inactivates all nucleases.  The extract is loaded onto a filtration 
column, which contains glass fibres that any nucleic acids present in the extract will 
selectively bind to.  Washes with the different buffers remove any contamination 
molecules from the column.  A low salt elution buffer releases the purified nucleic 
acids from the glass fibres and the extract can then be used in a PCR reaction (Galli, 
2006; Roche Diagnostics Ltd.).   
The kit is used routinely, in the CVRL, to extract DNA from cultures of M. 
avium subsp paratuberculosis (M. paratuberculosis), which has a much tougher cell 
wall than M. bovis.  
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4.1.3 Immunomagnetic Separation 
The third method evaluated was Immunomagnetic Separation (IMS).  This is a 
technique used for the extraction of a desired cell from a heterogeneous cell 
suspension (Grant et al., 1998).  IMS has been successfully applied to the detection of 
M. paratuberculosis from spiked and natural infected milk samples (Grant et al., 
1998; Djønne et al., 2003) and from faecal samples (Khare et al., 2004).  The 
technique has been used to isolate M. avium from stool samples from AIDS patients 
(Li et al., 1996) and M. tuberculosis in cerebrospinal fluid (Mazurek et al., 1996).  M. 
bovis was detected, using IMS, from spiked milk samples (Antognoli et al., 2001).  
The successful adaptation of IMS to isolate mycobacteria from other sample types 
indicates the effectiveness of this technique. 
IMS relies on the interaction between cell surface antigens and antibodies 
bound to paramagnetic beads.  The application of a strong magnetic field allows the 
target cells to be separated from the suspension.  After IMS, the bead bound cells can 
be resuspended in a smaller volume, which allows for concentration of the target 
cells.   IMS is a powerful yet gentle technique for concentration of a target cell since 
no potentially harmful chemicals are used during the procedure.  Consequently the 
physiological state of the cells is not affected (Grant et al., 1998).  
 
4.1.4 GenoType Mycobacteria Direct 4.0 
The fourth method evaluated was the propriety detection method GenoType 
Mycobacteria Direct 4.0 (GTMD, Hain Lifesciences). GTMD, version 4.0, is an assay 
based on Nucleic Acid Sequence Based Amplification (NASBA) and DNA strip 
technology.  It allows for the direct detection of MTBC, M. avium, Mycobacterium 
malmoenese, Mycobacterium intracellulare and Mycobacterium kansasii, by 
amplification of 23S rRNA, from decontaminated clinical samples (Franco-Álvarez 
de Luna et al., 2006).   This kit has been used to successfully detect mycobacteria 
directly from decontaminated sputum samples and a limited number of other sample 
types including tissue biopsies, cerebrospinal fluid and pleural fluids (Seagar et al., 
2008; Franco-Álvarez de Luna et al., 2006; Fakrin et al., 2007; Kiraz et al., 2010; 
Neonakis et al., 2009). 
The assay is divided into three parts.  The initial part is a magnetic bead 
capture and RNA extraction procedure. 
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The second stage in the process is a NASBA process, which is an isothermic 
cyclical series of reactions, shown in Figure 4.1.  The reaction mixture contains 
nucleoside triphosphates, buffer components, two oligonucleotide primers and three 
enzymes, T7 RNA polymerase, reverse transcriptase and RNaseH, which work 
together to amplify sequences from a single stranded RNA template.  The first primer 
binds to the RNA, which allows the reverse transcriptase to synthesise a 
complementary DNA (cDNA) strand.  The RNaseH digests away the RNA template.  
A second primer binds to the cDNA and reverse transcriptase forms a double-stranded 
cDNA.  The double stranded cDNA then acts as a mini “gene” which T7 RNA 
polymerase uses to produce RNA transcripts.  These RNA transcripts then cycle 
though the reaction (Cook, 2003). 
The amplified RNA product is then reverse hybridised onto a thin strip, which 
has immobilised gene probes on its surface.  A Streptavidin-conjugated alkaline 
phosphate is used to carry out a colorimetric detection on the hybridised samples with 
an appropriate substrate.  Different banding patterns correspond to the isolate 
identification.  An internal RNA control is included in each sample, during the 
NASBA step, to indicate if any inhibitory substances are present in the sample 
(Seagar et al., 2008). 
 
4.1.5 Sequence Capture PCR 
The fifth method evaluated was sequence capture PCR.  This consists of a 
process that provides enrichment of a specific target sequence and removal of PCR 
inhibitory substances.  This method was included with this study since it has been 
successful for the direct detection of M. bovis in lymph node tissue and 
decontaminated tissue homogenates (Roring et al., 2000; Mangiapan et al., 1996; 
Parra et al., 2008).   The technique has also been used for the detection of M. 
paratuberculosis from faeces (Marsh et al., 2000; Marsh and Whittington, 2001; 
Halldórsdóttir et al., 2002) and M. ulcerans from water and plant material (Stinear et 
al., 2000).  
Samples are mechanically disrupted and enzymatically digested.  Biotinylated 
capture oligonucleotides are added to the crude extract and allowed to hybridise.  
Streptavidin coated paramagnetic beads are added to the sample and bind to the 
hybridised biotinylated oligonucleotides.  A strong magnetic force is applied and the 
target sequences are retained, with the beads, and the remainder of the sample is   
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Figure 4.1: Schematic Diagram of a NASBA reaction.  Adapted from Monis et al., 
2005. 
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discarded.  The samples can be used for PCR immediately or the captured sequences 
can be released from the magnetic beads by a heat treatment step (Roring et al., 1998; 
Roring et al., 2000; Mangiapan et al., 1996; Parra et al., 2008).    
Each of the methods evaluated as part of this study have been used to prepare 
mycobacterial DNA for PCR but only Sequence Capture PCR has been successfully 
used to detect M. bovis directly from lymph node tissue. 
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4.2 Results 
A total of 30 lymph node tissue samples were cultured, as per section 2.1, and 
classified as described in section 2.11.  The remainder of the decontaminated culture 
material, following inoculation of the culture media, was divided into 0.5 ml aliquots 
and stored at -20
o
C.  From the 30 tissue samples, there were 27 MTBC culture 
positive tissues and 3 culture negative tissues.  Due to the limited amount of 
decontaminated culture material available not all samples were used on each 
procedure described below.  
  
4.2.1 Heat Lysis 
To determine if a heat lysis extraction procedure could be used to extract 
MTBC DNA from decontaminated tissue samples, all of the samples were diluted as 
described in section 2.12, heat killed as per section 2.13 and a heat lysis extraction 
was carried out as per section 2.14.  The samples were split into three groups, for 
convenience, and each group was heat killed with MTBC positive solid culture and a 
PBS blank, 500 µl of PBS, included as controls.  All three sample groups were heat 
killed separately, on different days, and heat lysed on the same day at different times.  
All 30 decontaminated samples and controls were amplified and detected together. 
Heat lysis is a simple and efficient method of extracting nucleic acids from 
cells but it failed to extract a detectable amount MTBC DNA from the 30 
decontaminated tissues, shown in Figure 4.2, Figure 4.3, Figure 4.4 and Figure 4.5.  
This was probably due to the low number of MTBC cells in the sample and DNA 
from non-MTBC cells, such as contaminating bacteria and cells from the lymph node 
tissue. The presence of PCR inhibitors in the final extract since the centrifugation 
step, after heat lysis, will remove the heavier cell debris but not the smaller 
contaminating molecules may also have contributed to the failure of this method. 
DNA was extracted from each of the MTBC positive cultures, Figure 4.2, 
Lane 16-17, Figure 4.3, Lane 18-19 and Figure 4.4, Lane 6-7.  The PCR blank 
control, which tests for contaminating DNA in the clean room when the PCR mix was 
prepared, and the PCR water control, which tests for contaminating DNA when the 
extracted DNA is inoculated into the PCR mix, were both negative, Figure 4.5.  The 
PCR M. bovis DNA control did give a band on the gel, which is shown in Figure 4.5.  
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Figure 4.2: Gel showing PCR product of samples extracted with a heat lysis 
procedure.  Lanes 1 & 22 50bp ladder, lanes 2-9, 12-15 and 18-21 decontaminated 
tissue samples, lanes 10-11 PBS blank and lanes 16-17 MTBC culture.  
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Figure 4.3: Gel showing PCR product of samples extracted with a heat lysis 
procedure.  Lanes 1 & 22 50bp ladder, lanes 2-7, 10-17 and 20-21 decontaminated 
tissue samples, lanes 8-9 PBS blank and lanes 18-19 MTBC culture. 
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Figure 4.4: Gel showing PCR product of samples extracted with a heat lysis 
procedure. Lanes 1 & 22 50bp ladder, lanes 2-15 and 18-21 decontaminated tissue 
samples and lanes 16-17 PBS blank. 
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Figure 4.5: Gel showing PCR product of samples extracted with a heat lysis 
procedure. Lanes 1 & 18 50bp ladder, lanes 2-5 and 8-13 decontaminated tissues 
samples, lane 6-7 MTBC culture, lane 14 PCR water control, lane 15 PCR blank and 
lane 16-17 PCR M. bovis DNA control. 
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4.2.2 Roche High Pure PCR Template Preparation Kit 
To determine if the Roche High Pure PCR Template Preparation Kit (High 
Pure Kit) would be able to extract MTBC DNA from decontaminated tissue samples. 
Samples 1-10 of the decontaminated tissue samples were removed from the    
–20oC freezer, heat killed as described in section 2.13 and treated by High Pure Kit as 
described in section 2.15.  All the tissue material in these samples had not been 
completely broken down by the lysis buffer and Proteinase K digestion when placed 
in the filter column.  The columns became clogged with the excess tissue material and 
only some liquid was able to pass though.  The samples were discarded since the 
extraction was unable to proceed.  To prevent wastage of the limited amount of 
decontaminated tissue for each sample, the initial 10 tissues were not retested with the 
pre-dilution step. 
Samples 11-30 of the decontaminated tissue pellets were removed from the     
-20
o
C freezer, diluted as per section 2.12, heat killed as per section 2.13 and treated 
by High Pure Kit as described in section 2.15 with the addition of an extra step.  After 
the incubation of the sample with Binding Buffer (BB) and Proteinase K any 
undigested tissue within the sample were discarded by centrifugation, at 5900 g for 1 
min.  The supernatant was transferred to the filter column and pellet was discarded.  
An MTBC positive solid culture was used as a positive control and PBS was used as a 
Blank.  All the 20 decontaminated tissue samples and controls were heat killed, 
extracted with the High Pure kit, amplified and detected, on 3 separate gels due to 
space constraints, at the same time. 
No DNA was detected from the PBS blank and any of the decontaminated 
tissue samples, Figure 4.6, Figure 4.7 and Figure 4.8.    DNA was extracted from the 
MTBC positive solid culture, shown in Figure 4.8, Lane 8-9.   
Pre-dilution of each sample, to an equal settled tissue volume, before testing, 
as described in section 2.12, was selected over a set dilution, such as 1 in 2 dilution, 
since each of the decontaminated tissues had a different settled tissue volume.  A 
sample with the larger volume of tissue may have been at a disadvantage, since some 
MTBC cells may have remained in the undigested tissue, for extraction of MTBC 
DNA compared to a sample with a smaller tissue volume.  The practical effect of this 
was that some samples were diluted up to 1 in 5 while others required no dilution at 
all.   The amount of tissue that required digestion was similar for each sample but the 
load of any MTBC cells for the diluted samples was reduced. 
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Figure 4.6:  Gel showing PCR product from tissue samples after use of High Pure Kit, 
Lane 1 & 20 50bp ladder, Lane 2-19 decontaminated tissue samples.  
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Figure 4.7: Gel showing PCR product from tissue samples after use of High Pure Kit, 
lane 1 & 20 50bp ladder, Lane 2-19 decontaminated tissue samples. 
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Figure 4.8: Gel showing PCR product from tissue samples after use of High Pure Kit.  
Lane 1 & 14 50bp ladder, Lanes 2-5 decontaminated tissue samples, Lane 6-7 PBS 
blank, Lane 8-9 MTBC culture, Lane 10 PCR water control, Lane 11 PCR blank 
control and Lane 12-13 PCR M. bovis DNA control. 
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Even with pre-dilution of the samples, the tissue was not fully digested prior to 
addition of the sample to the filter column and a centrifugation step was required.    
The failure to digest all the tissue present meant that it was probable that some MTBC 
cells would be discarded with the undigested tissue which would reduce the yield of 
any MTBC DNA from the column. 
Modifications were made to the pre-treatment of the decontaminated tissue 
samples prior to use of High Pure Kit, section 2.16, to determine if these changes 
would allow the extraction MTBC DNA from the tissues. 
To avoid wasting reagents and sample material only 12 of the 30 
decontaminated tissue samples, 2 culture negative and 10 culture positive tissues, 
were tested using this modified procedure.  The decontaminated tissue samples were 
diluted as per section 2.12, heat killed with controls, 2 MTBC positive solid cultures 
and a PBS blank, as per section 2.13 and treated by High Pure Kit as described in 
section 2.16.  The samples were amplified and detected as described in section 2.23 
and 2.25, using a 100bp DNA ladder (BioLabs, Cat #: N3231S).  
The modifications to the testing procedure did ensure that all the tissue was 
digested prior to addition of the sample to the column but no MTBC DNA was 
detected in any of the decontaminated tissue samples, Figure 4.9 and 4.10.  Both 
MTBC positive controls were extracted and detected on the gel, Figure 4.10, lane 6-9, 
and no DNA was detected from the PBS blank.   
Several of the decontaminated tissue samples, Figure 4.9 and 4.10, had smears 
on the gel which could be caused by excess DNA in the sample or the formation of 
primer dimers during PCR amplification. Each sample was diluted 1 in 10, with 
UltraPure Distilled Water, to ensure that excess DNA was not the cause of the failure 
to detect MTBC DNA, amplified as per section 2.23 and detected as per section 2.25.  
The kit would have removed most, if not all of the PCR inhibitors with the samples 
but the extract would contain nucleic acids from non-MTBC cells.  Many of the non-
MTBC cells would have been destroyed during the decontamination process but due 
to the low MTBC load within a given tissue they still would be a significant source of 
contaminating nucleic acids.  Any MTBC DNA present would also have been diluted.  
If primer dimers are the cause of smears on the gel then dilution of the sample should 
have no effect on their formation and the PCR conditions, MgCl2 concentration, 
reaction temperatures, nucleotide concentration etc., would need to be altered to 
minimise their formation. 
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Figure 4.9: Gel showing PCR product from a modified procedure for High Pure Kit. 
Lane 1 & 20 100bp ladder, Lane 2-19 decontaminated tissue samples. 
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Figure 4.10: Gel showing PCR product from a modified procedure for the High Pure 
Kit.  Lane 1 & 18 100bp ladder, Lane 2-5 & 12-13 decontaminated tissue samples, 
lane 6-9 MTBC cultures, Lane 10-11 PBS Blank, Lane 14-15 PCR M. bovis DNA 
control, Lane 16 PCR water and Lane 17 PCR blank. 
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The gels, shown in Figure 4.11 and 4.12, indicate that excess DNA in the 
extracted sample is not the explanation for the absence of bands on the gels.  Neither 
is the formation of primer dimers since the smears on the gel are much reduced and 
the PCR conditions were not altered. 
The High Pure Kit is designed to purify nucleic acids from other 
contaminating molecules but it cannot select for nucleic acids from a particular cell 
type within a mixture of cells making it unsuitable for extraction of MTBC DNA from 
decontaminated tissues. 
 
4.2.3 Immunomagnetic Separation 
To determine if IMS coupled with a Heat Lysis Extraction can be used to 
extract MTBC cells from decontaminated tissue samples, 30 decontaminated tissue 
samples were diluted as per section 2.12 and tested, with a MTBC positive solid 
culture and PBS blank, on the same day, as per section 2.17.  The product was 
amplified and detected as per section 2.23 and 2.25.   
IMS did not isolate any MTBC cells from the decontaminated tissues, Figure 
4.13 and 4.14. Possible explanations for this include the presence of molecules, such 
as immunoglobulins, in the lymph node tissue that could interact with the variable 
regions M. tuberculosis Mouse Monoclonal Ab or with the surface antigens (Ag) on 
the MTBC cells thus preventing the Antibody-Antigen binding reaction from taking 
place.  Proteases, that may be present in the LN tissue, could non-specifically digest 
the M. tuberculosis Mouse Monoclonal Ab before it had a chance to bind to the 
antigens on the surface of the MTBC cells (Fu et al., 2005).   
IMS did detect MTBC cells in the positive control sample tested, Figure 4.14 
Lane18-19.  Care was taken to ensure that only MTBC cells bound to the magnetic 
beads remained in the extract that was heat killed.  The wash step was repeated a total 
of 3 times and all the supernatant, following application of the magnetic field, was 
carefully removed from each sample. 
Dilution of the decontaminated tissue samples would reduce the concentration 
of any molecules that could interfere with the IMS.  To determine if the amount of 
tissue in the sample is inhibiting the IMS of MTBC cells, 9 decontaminated tissue 
samples were diluted as described in section 2.12. Each sample was further diluted by 
1/10 with PBS, a MTBC positive solid culture was also diluted 1/10 with PBS, and 
the IMS procedure continued as described in section 2.17.  
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Figure 4.11: Gel showing 1/10 dilution of PCR product from a modified procedure for 
the High Pure Kit.  Lane 1 & 20 100bp ladders, Lane 2-19 decontaminated tissue 
samples. 
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Figure 4.12: Gel showing 1/10 dilution of PCR product from a modified procedure for 
the High Pure Kit.  Lane 1 & 18 100bp ladder, lane 2-5 & 12-13 decontaminated 
tissue samples, Lane 6-9 MTBC cultures, Lane 10-11 PBS blank, Lane 14-15 PCR M. 
bovis DNA control, Lane 16 PCR water and Lane 17 PCR blank. 
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Figure 4.13:  Gel showing PCR product from IMS and HL.  Lane 1 & 36 50bp 
Ladder, Lane 2-35 decontaminated tissue samples. 
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Figure 4.14: Gel showing PCR product from IMS and HL. Lane 1 & 36 50bp ladder, 
Lane 2-7, 10-17 and 20-30 decontaminated tissue samples, Lane 8-9 PBS blank, Lane 
18-19 MTBC culture, Lane 32 PCR water control, Lane 33 PCR blank, Lane 34-35 
PCR M. bovis DNA control. 
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A 1 in 10 dilution of the samples, some of which had already been diluted as 
per section 2.12, did not improve the detection of MTBC cells with IMS, Figure 4.15 
and 4.16.  Dilution may reduce the amount of contaminating molecules and cells in 
the sample but it would have also reduced the number of MTBC cells by the same 
amount. 
Pre-treatment of the samples prior to IMS is required to remove or destroy the 
remaining LN tissue, which may hamper the movement of the bound magnetic beads 
though the sample, and any contaminating molecules.  The choice of pre-treatment is 
limited to centrifugation or mechanical disruption since any enzymatic and chemical 
treatment could adversely affect the antibody-antigen binding reaction.  This is due to 
the difficulty with complete removal of any lysis buffer or enzyme, used to digest the 
tissue, from the target cells.  Even a small amount of lysis buffer or enzyme remaining 
could easily destroy the antibodies bound to the magnetic beads leading to false 
negative results. 
Due to the small sample size and the existing centrifugation step, a mechanical 
disruption, in the form of bead beating of the samples, was selected for a pre-
treatment prior to IMS.  This method was selected since it is suitable for use on a 
small sample volume, it was carried out in an enclosed tube, limiting the risk of cross-
contamination, and different sized glass beads could be selected to prevent damage to 
any MTBC cells.  It should be noted that none of the decontaminated LN tissues 
samples contained any noticeable pieces of tissue.   
To determine if addition of a bead-beating pre-treatment would allow IMS to 
extract MTBC cells from decontaminated tissue samples, 9 tissue samples were 
diluted as per section 2.12.  A bead-beating step was added as per section 2.18 and the 
samples then processed for IMS as per section 2.17.  Three MTBC positive solid 
cultures were used as controls, one was not pre-treated, and the other two were treated 
as per section 2.18 with, 0.5 ml of 212-300 μm beads used on one MTBC culture and 
in the second 0.5 ml of 710-1180 μm beads (Sigma, Cat #: G1152) were used.   
The addition of this step did not improve the isolation of MTBC cells from the 
tissue, as in Figure 4.17 and 4.18, which shows the results after 30 sec of bead-
beating.  Only the results of 30 sec of bead-beating are shown since all the results 
were identical.  IMS was able to detect all the MTBC positive culture controls 
regardless of the length of time the samples were in the Ribolyser or the size of beads 
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Figure 4.15: Gel showing PCR product from IMS and HL after 1/10 dilution of the 
decontaminated tissue sample.  Lane 1 & 16 50bp ladder, Lane 2-7 & 10-15 
decontaminated tissue samples, Lane 8-9 PBS blank. 
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Figure 4.16: Gel showing PCR product from IMS and HL after 1/10 dilution of the 
decontaminated tissue sample. Lane 1 & 14 50bp Ladder, Lane 2-5 & 8-9 
decontaminated tissue samples, Lane 6-7 1/10 dilution of MTBC culture, Lane 10-11 
PCR M. bovis DNA control, Lane 12 PCR water control, Lane 13 PCR blank control. 
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Figure 4.17 Gel showing PCR product from IMS and HL after bead-beating for 30sec 
(C). Lane 1 & 20 50bp ladder, Lane 2-9, 12-17 decontaminated tissue samples, Lane 
10-11 PBS blank, Lane 18-19 MTBC culture (710-1180μm beads). 
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Figure 4.18: Gel showing PCR product from IMS and HL after bead-beating for 30sec 
(C). Lane 1 & 14 50bp ladder, Lane 2-5 decontaminated tissue samples, Lane 6-7 
MTBC culture (no bead-beating), Lane 8-9 MTBC culture (212-300μm beads), Lane 
10-11 PCR M. bovis DNA control, Lane 12 PCR water control, Lane 13 PCR blank 
control. 
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used, Figure 4.17 Lane 18-19 and Figure 4.18 Lane 6-9.  This indicates that the 
MTBC cells were still intact after bead-beating with the different sized beads.  
The effectiveness of the bead-beating step could have been improved by the 
use of smaller glass beads such as <106 m in size.  The risk with using the smaller   
beads is that any MTBC cells in the sample could be damaged and they need to be 
intact for IMS to be successful.  Increasing the length of the bead-beating step, past 
40sec, may increase the effectiveness of this technique but again runs the risk of 
destroying any MTBC cells in the sample.  The technique is also limited in that it 
cannot remove any of the small molecules in the sample, which could interfere with 
the Antibody-Antigen binding reaction.   
There is a possibility that IMS failed previously due to antibody bound beads 
not having enough time to locate and bind to the low number of MTBC cells within 
the sample.  To determine if increasing the time the antibody bound beads are allowed 
to interact with the decontaminated tissue sample would allow IMS to extract MTBC 
cells from the samples, 9 tissue samples were diluted as per section 2.12.  The IMS 
procedure was carried out as per section 2.17 with the antibody bound beads allowed 
to interact with the decontaminated tissue samples for 30 min (W), 60 min (X), 120 
min (Y) and 180 min (Z).  A MTBC positive solid culture and PBS blank were 
included with each set of decontaminated tissue samples. 
Increasing the incubation time of the antibody bound beads with the 
decontaminated tissue sample had no effect on the detection of MTBC cells using 
IMS, Figure 4.19 and 4.20 showing the result after 180 min (Z).  All the MTBC 
positive cultures were identified and no DNA was found in the PBS samples.  IMS 
technique may not be sensitive enough to detect the low numbers of MTBC cells that 
would be present in the decontaminated tissues.    
To determine the sensitivity of IMS, a comparison was made between the 
limits of detection with a serial dilution of a M. bovis culture spiked into PBS and into 
a culture negative decontaminated lymph node tissue, described in section 2.19.  A 
single negative decontaminated tissue pellet was resuspended in the PBS which was 
used as a negative control for the dilution series.  A second set of each M. bovis stock 
dilution was tested just in PBS.  The IMS procedure was carried as per section 2.17 
and the product was amplified and detected as per section 2.23 and 2.25. 
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Figure 4.19: Gel showing PCR product from IMS and HL after incubation with 
antibody bound beads for 180 min (Z).  Lane 1-10 decontaminated tissue samples, 
Lane 11 50bp ladder. 
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Figure 4.20: Gel showing PCR product from IMS and HL after incubation with 
antibody bound beads for 180 min (Z). Lane 1 & 18 50bp Ladder, Lane 2-3, 6-9 & 
12-13 decontaminated tissue samples, Lane 4-5 PBS blank, Lane 10-11 MTBC 
culture, Lane 14-15 PCR M. bovis DNA control, Lane 16 PCR water control and 
Lane 17 PCR blank control. 
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IMS was able to detect M. bovis, in PBS, down as far as 1 x 10
-2
 dilution, 
Figure 4.21 and 4.22, and this corresponds to 2.3 x 10
2 
cfu/ml of M. bovis.  In PBS, 
which should contain no molecules to interfere with IMS, the limits of detection for 
M. bovis was similar to that of culture, shown section 3.2, of 2.5 x 10
2 
cfu/ml.  
However, when the serial dilution of M. bovis was spiked into culture negative 
decontaminated lymph node tissue the sensitivity dropped by a factor of 10 to 2.3 x 
10
3 
cfu/ml of M. bovis, Figure 4.23 and 4.24.  It is clear from the above results the 
difficulty of using IMS to isolate MTBC cells from decontaminated tissue samples.  
As stated previously, there is no way to remove molecules, such as immunoglobulins 
and proteases, which could interfere with IMS without inhibiting with the Ab-Ag 
binding reaction.  All the control gave the expected results. 
Another possible explanation for the increased limit of detection of M. bovis 
with IMS in decontaminated tissues is the difficulty of a magnetic bead, bound to a 
MTBC cell, moving through the tissue sample after application of the magnetic field.  
A MTBC cell bound to a single magnetic bead would move slower through the tissue 
than MTBC cell bound to multiple beads.  Due to the size of the 4.5 micron magnetic 
bead in relation to the size of a MTBC cell, steric hindrance may limit the number of 
magnetic beads that could attach to any given MTBC cell.  Using a smaller magnetic 
bead of 2.8 m may allow more beads to bind to a single MTBC cell and may modify 
the limits of detection. 
The limits of detection of M. bovis with IMS in decontaminated tissue samples 
and PBS, described above, was repeated using smaller magnetic bead for the 
separation step.  IMS was carried out as described in section 2.17 with the use of 
Dynabeads® M-280 Sheep Anti-Mouse IgG (Dynal, Cat No.: 112-01D), which have a 
diameter of 2.8 μm, instead of the Dynabeads® Sheep-anti Mouse IgG (Dynal, Cat 
No.: 110-31), which have a diameter of 4.5 μm. 
Reducing the diameter of the beads used with IMS, from 4.5 μm to 2.8 μm, 
had no effect on the limits of detection of M. bovis spiked into either PBS or 
decontaminated tissue.  IMS on the serial dilution of M. bovis in PBS was able to 
detect down to 1 x 10
-2
, which corresponds to 2.3 x 10
2 
cfu/ml of M. bovis, Figure 
4.25 and 4.26.  When the M. bovis dilutions were spiked into culture negative 
decontaminated lymph node tissues the limits of detection of IMS fell to 1 x 10
-1
, or  
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Figure 4.21: Gel showing product from IMS and HL on serial dilution of M. bovis 
spiked into PBS.  Lane 1 & 14 50bp Ladder, Lane 2-12 serial dilution of M. bovis, 
1x10
-1
 – 1x10-6. 
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Figure 4.22: Gel showing product from IMS and HL on serial dilution of M. bovis 
spiked into PBS. Lane 1 & 14 50bp ladder, Lane 2-5 serial dilution of M. bovis, 1x10
-
7
 – 1x10-8, Lane 6-7 MTBC culture, Lane 8-9 PBS blank, Lane 10 & 12 PCR M. bovis 
DNA control, Lane 11 PCR water control and Lane 13 PCR blank control. 
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Figure 4.23: Gel showing product from IMS and HL on serial dilution of M. bovis 
spiked into negative decontaminated tissue sample.  Lane 1 & 12 50bp Ladder, Lane 
2-11 serial dilution of M. bovis, 1x10
-1
 – 1x10-5. 
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Figure 4.24: Gel showing product from IMS and HL on serial dilution of M. bovis 
spiked into negative decontaminated LN sample. Lane 1 & 16 50bp ladder, Lane 2-7 
serial dilution of M. bovis, 1 x 10
-6
 – 1 x 10-8, Lane 8-9 MTBC culture, Lane 10-11 
PBS blank, Lane 12 and 14 PCR M. bovis DNA control, Lane 13 PCR water control 
and Lane 15 PCR blank control. 
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Figure 4.25 Gel showing product from IMS and HL on serial dilution of M. bovis, in 
PBS, using M-280 beads (2.8 μm beads).  Lane 1 & 14 50bp Ladder, Lane 2-12 serial 
dilution of M. bovis, 1x10
-1
 – 1x10-6. 
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Figure 4.26: Gel showing product from IMS and HL on serial dilution of M. bovis, in 
PBS, using M-280 beads (2.8 μm beads). Lane 1 & 14 50bp ladder, Lane 2-5 serial 
dilution of M. bovis, 1 x 10
-7
 – 1 x 10-8, Lane 6-7 MTBC culture, Lane 8-9 PBS blank, 
Lane 10-11 PCR M. bovis DNA control, Lane 12 PCR water control and Lane 13 
PCR blank control. 
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2.3 x 10
3 
cfu/ml, Figure 4.27 and 4.28, the band is faint but it is present.    All the 
controls gave the expected results. 
IMS has been used to extract mycobacteria from a variety of different sample 
types, as described section 4.1.3.  The results shown here clearly indicate that IMS is 
not a suitable technique for the direct detection of MTBC cells in decontaminated 
lymph node tissue. 
 
4.2.4 GenoType Mycobacteria Direct 4.0 
To determine if the GenoType Mycobacteria Direct Kit can be used to detect 
mycobacteria in decontaminated tissue samples, the GTMD kit was carried out as per 
section 2.20.  Twelve samples at a time could be processed by the Twincubator® with 
hybridization block.  Each run included the kit positive control RNA and up to 11 
decontaminated tissue samples.  One run included a PBS blank and a MTBC positive 
solid culture. 
The GTMD did not perform well for the direct detection of MTBC cells from 
decontaminated tissues, only correctly identifying 6 out of 30 decontaminated tissue 
samples and giving two false negative results, Table 4.1 and sample result sheet 
Figure 4.29.  The false negative results are not problematic but failure of the 
remaining 22 samples was due to inhibition of the NASBA reaction.  This was 
indicated by the development of the CC (conjugate control) band, first band, on the 
strip only.  Each sample had an Internal Control RNA added to it during the extraction 
procedure which should be amplified during the NASBA reaction.  This amplification 
may be inhibited by the presence of nucleic acids from the sample.  As a result of this, 
every band on the strip, except the CC, must be stronger than the UC (universal 
control) band, second band on the strip, to be considered relevant.   
Many factors could have led to failure of the NASBA reaction including the 
presence of contaminating molecules in the extract following the MB separation.  
This may be due to failure to remove all of the supernatant after each magnetic bead 
wash step or magnetic beads still remaining in the sample following the final 
separation.  The problem may be with the NASBA reaction mix such as the PMN mix 
may have been left standing too long before being used and the EML may have been 
mixed too much prior to use.  Another issue may be the presence of excess tissue in 
some samples since pre-dilution, as per section 2.12, was not carried out.   
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Figure 4.27: Gel showing product from IMS and HL, using M-280 beads (2.8 μm 
beads), on serial dilution of M. bovis spiked into negative decontaminated tissue.  
Lane 1 & 12 50bp Ladder, Lane 2-11 serial dilution of M. bovis, 1x10
-1
 – 1x10-5. 
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Figure 4.28: Gel showing product from IMS and HL, using M-280 beads (2.8 μm 
beads), on serial dilution of M. bovis spiked into negative decontaminated tissue 
sample. Lane 1 & 16 50bp ladder, Lane 2-7 serial dilution of M. bovis, 1 x 10
-6
 – 1 x 
10
-8
, Lane 8-9 MTBC culture, Lane 10-11 PBS blank, Lane 12-13 PCR M. bovis 
DNA control, Lane 14 PCR water control and Lane 15 PCR blank control. 
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Table 4.1:  The results of the GenoType Mycobacteria Direct kit testing 27 MTBC 
positive and 3 culture negative decontaminated tissue samples. 
 
 
 
 
 
 
 
 
 
 
Figure 4.29: Sample result sheet showing the results of 11 tissue samples and the 
positive control RNA supplied with the kit. 
 
 
 
 
 MTBC Neg Fail 
High (7) 4   3 
Medium (9)   1 8 
Low (11) 2 1 8 
Total (27)  6  2 19 
Negative (3)   3 
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It should be noted that the Positive Control RNA, supplied with the kit, failed 
to give a conclusive banding pattern, e.g. Sample 7 in Figure 4.29.  The control was 
prepared and tested as per kit instructions.  As soon as bands appeared on its test strip 
the reaction was stopped with distilled water but a clear banding pattern was not seen.  
This may have been due to problems with the NASBA reaction such as the delay 
between the time the PNM was made up and its use or excess agitation of the EML 
before utilization  
The GTMD kit was repeated with modifications to the sample preparation and 
care was taken to ensure that all liquid following each magnetic bead separation was 
carefully removed, all NASBA reagents were made up correctly and as close to the 
time of use as possible.  The GTMD kit was carried out as per section 2.21 and each 
decontaminated tissue sample was diluted as per section 2.12.  To ensure that no 
magnetic beads remained in the sample tube after last magnetic bead separation each 
tube was centrifuged at 5900 g for 1 min.  The supernatant was transferred to a fresh 
tube and used in the amplification step and the pellet was discarded.  Instead of the 
PNM being made up in the clean room about an hour before it was required, it was 
made up immediately prior to use within the TB Laboratory, approximately 15 min 
prior to use.  This was carried out in a BSC (biological safety cabinet) that was not 
used for any other molecular biology work.  The cabinet was suitably cleaned and 
treated with UV light prior to use.  Care was taken to ensure the EML was prepared 
with gentle mixing only. 
The minor changes made to the test procedure did not improve the 
effectiveness of the GTMD kit, Table 4.2 and sample result sheet Figure 4.30.   From 
the above table it can be seen that the kit failed for 23 decontaminated tissue samples 
and only correctly identified 4 MTBC positive decontaminated tissue samples and 
gave 3 false negative results.   
Again the positive control RNA supplied with the kit failed to give a clear 
banding pattern e.g. sample labelled PK on Figure 4.30, but this may be due to the 
problems causing the failure of the NASBA reaction with the decontaminated tissue 
samples.  A MTBC positive solid culture was processed with the tissue samples and 
the kit correctly identified this sample, Sample labelled Pos on Figure 4.30 
A pre-treatment of the decontaminated tissues, prior to testing with the GTMD 
kit, appears to be necessary.  No pre-treatment information was supplied with the kit 
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and since not enough information was provided with the kit to identify a suitable pre-
treatment the manufacturer was contacted for assistance.    
The manufacturer supplied the pre-treatment protocol, involving an enzymatic 
digestion, which was carried out as per section 2.21.  The GTMD kit correctly 
identified 19 out of the 30 decontaminated tissue samples and had 5 false negative 
results, Table 4.3 and sample result sheet Figure 4.31.  The false negative results may 
be due to the low number of MTBC cells in the samples, particularly following the 
dilution of the samples, as per section 2.12, prior to carrying out the GTMD kit.   
The GTMD kit gave no false positive results, however this is not a definitive 
conclusion since it is based only 3 MTBC culture negative samples included in the 
study, 2 of which failed.   A total of 6 samples failed, giving only a CC band on the 
test strip, Table 4.3 and sample result sheet Figure 4.31.  The reason for this failure is 
unknown but these tissues may contain NASBA reaction inhibitors that were not fully 
removed by the magnetic bead extraction.   These results were an improvement on the 
samples tested with the kit without the enzymatic digestion.   
A persistent problem with this kit was the failure of the positive control 
supplied with the kit to give a clear banding pattern.  There was no clear reason for 
this failure.  All reagents supplied with the kit were used in date, correctly stored and 
the directions for use of the positive control were followed carefully.  Different kit lot 
numbers have been used over the repeated testing of the decontaminated tissue 
samples with the GTMD kit.  To ensure that the kit was performing correctly two 
MTBC positive solid culture controls were included with each test run to act as 
positive controls.  One aliquot of the positive control was pre-treated with an 
enzymatic digestion with the tissue samples, Figure 4.31 Sample 5, and the second 
was tested without the digestion, Figure 4.31 Sample 12.  Both controls gave an 
MTBC banding pattern. 
Since the GTMD kit, with the addition of an enzymatic pre-treatment has been 
shown to detect MTBC cells in decontaminated tissue samples, a limit of detection 
study was carried out with a M. bovis stock spiked into culture negative 
decontaminated tissue samples as described in section 2.19.  One negative 
decontaminated tissue pellet was resuspended in the PBS that was used as a negative 
control for the dilution series.  Two samples of the neat M. bovis stock was tested 
without spiking into the decontaminated tissue, a PBS sample and the positive control 
supplied with the kit were also tested. 
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Table 4.2:  The results of the GenoType Mycobacteria Direct kit testing 27 MTBC 
positive and 3 negative decontaminated tissues. 
 
 
 
 
 
 
 
 
 
 
Figure 4.30: Sample result sheet showing the results of 9 tissue samples and three 
controls, a MTBC culture, PBS blank and the positive control RNA supplied with the 
kit. 
 
 MTBC Negative Fail 
High (7) 1 1 5 
Medium (9) 1 1 7 
Low (11) 2 1 8 
Total (27) 4 3 20 
Negative (3)   3 
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Table 4.3: The results from the GenoType Mycobacteria Direct kit with addition of an 
overnight Proteinase K digestion.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.31: Sample result sheet showing the results of 8 tissue samples and four 
controls with the addition of an overnight Proteinase K digestion. These include two 
MTBC cultures, the positive control supplied with the kit and a blank of PBS. 
 
 
 
 
 MTBC Negative Fail 
High (7) 4 2 1 
Medium (9) 7  2 
Low (11) 7 3 1 
Total (27) 18 5 4 
Negative (3)  1 2 
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All the samples were tested with the GTMD as described in section 2.20, 
excluding the positive control supplied with the kit and one neat M. bovis stock 
sample which were not enzymatically pre-treated. 
As can be seen from, Figure 4.32, the kit was able to detect the M. bovis 
spiked into the decontaminated tissue sample down to a dilution of 1 x 10
-2
.  This 
corresponds to a concentration of M. bovis of 2.3 x 10
2 
cfu/ml, which is a similar to 
the sensitivity of culture of 2.5 x 10
2 
cfu/ml, see section 3.2. 
The neat M. bovis samples, both digested and undigested, gave a MTBC band 
on the strip.  Both PBS samples gave a negative result.  The positive control supplied 
with the kit again showed an inconclusive banding pattern. 
This kit allows for a rapid turnaround of suspect TB positive sample.  The 
enzymatic digestion of the decontaminated tissue samples can be started after 
inoculation of the culture media.  The GTMD kit procedure takes a single day, 
meaning that a preliminary result could be available to be reported at the end of the 
following working day after culture.  For a definitive result the culture procedure 
would have to be allowed to run to completion, due to the presence of false negative 
results, described previously.   For the majority of suspect TB tissues received, which 
cannot be diagnosed by histopathology, there is no necessity for such a rapid 
turnaround of results.   For samples received from singleton reactor animals and tissue 
samples received from animals where there is a risk of infection to humans, such as 
household pets, this kit could be of great benefit as long as it was used in tandem with 
TB culture, rather than as replacement of it, due to false negative results.  
 
4.2.5 Sequence Capture PCR 
Sequence Capture PCR was the only one of the five methods evaluated that 
had previously been shown to detect M. bovis in decontaminated tissue samples 
(Roring et al., 1998; Roring et al., 2000; Mangiapan et al., 1996; Parra et al., 2008).  
The aim of this section was to determine if Sequence Capture PCR can detect MTBC 
cells in the 30 decontaminated tissue samples.  The tissue samples were diluted as per 
section 2.12 and the sequence capture PCR was carried out as described in section 
2.22.   
The decontaminated tissue samples were split into four groups for testing.  
With each group a MTBC positive solid culture and PBS blank were included for the 
complete extraction procedure.  At the sequence capture step 5 μl of M. bovis DNA
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Figure 4.32: Sample result sheet showing the results of limit of detection of GTMD 
kit with M. bovis spiked into decontaminated tissue samples.  
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was added to 545 μl of TES buffer to act as a positive control.  The product was 
amplified in a PCR mix containing Q solution and in a PCR mix in which no Q 
solution was used, as per section 2.24.  Q solution alters the melting behaviour of 
DNA and can improve a suboptimal PCR caused by templates high GC-content, like 
M. bovis (Qiagen, 2010).  The amplified PCR product from both mixes was detected 
as per section 2.25. 
The Tables 4.4 and 4.5 show that sequence capture was suitable for the 
detection of MTBC cells in decontaminated tissue samples.  The MTBC positive solid 
culture and M. bovis DNA controls gave a band of approximately 270 bp when 
amplified both with and without Q solution in the PCR mix.  No bands were detected 
with the PBS blank.   There was a difference in the results when sequence capture 
product was amplified with the use of Q solution, Table 4.4, and without Q solution, 
Table 4.5.  The percentage of false negatives with the Q solution was 56.67%, or 17 
out of 30 samples, and the percentage of false negative without the Q solution was 
26.67%, or 8 out of 30 samples.  An example of the difference in the detection of 
amplified product with and without the use of Q solution in the PCR mix is shown in 
Figure 4.33 and 4.34 for the same decontaminated tissue samples.   
The false negative results may be due to the low number of MTBC cells 
present in some tissues, since some samples were diluted, as per section 2.12, prior to 
testing.  Another possibility is the presence of molecules remaining in the sample after 
the mechanical and enzymatic pre-treatment, which could have prevented the binding 
of the oligonucleotides to the released DNA.   
Since sequence capture PCR, without the use of Q solution in the PCR mix, 
has been shown to be an effective method to detect MTBC cells in decontaminated 
tissue samples a limit of detection study for a M. bovis stock solution spiked into 
negative decontaminated tissue was carried out, as described in section 2.19.  A single 
negative decontaminated tissue pellet was resuspended in the PBS solution that was 
used in the dilution series.  A sequence capture PCR was carried out as described in 
section 2.22 and the product was amplified, without Q solution in the PCR mix, and 
detected as per section 2.24 and 2.25. 
Sequence Capture PCR was able to detect M. bovis DNA, in the spiked 
decontaminated, culture negative, tissue samples, down as far as the 1 x 10
-3
 dilution,   
though the bands for this dilution are faint on the gel, as shown in Figure 4.35, 4.36 
and 4.37.  This corresponds to 2.3 x 10
1 
cfu/ml of M. bovis, which is 10 times more 
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Table 4.4: Results of sequence capture PCR of 27 MTBC positive and 3 negative 
decontaminated tissue samples.  The DNA was amplified in a PCR mix containing Q 
solution. 
 
 
 
 
 
 
 
 
 
 
     1             3             5          7            9            11             13           15  
 
Figure 4.33:  Gel showing products of sequence capture PCR, amplified with Q 
solution. Lane 1-8 & 11-12 decontaminated tissue, Lane 9-10 PBS blank, Lane 13-14 
MTBC culture and Lane 15 50bp ladder. 
  
SQCap with Q MTBC Neg 
High (7) 4 3 
Medium (9) 5 4 
Low (11) 1 10 
Total (27)  10 17 
Negative (3)  3 
PBS 
Blank 
Tissue 
1 
Tissue 
2 
Tissue 
3 
Tissue 
4 
Tissue 
5 
MTBC 
Culture 
270bp 
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Table 4.5: Results of sequence capture PCR of 27 MTBC positive and 3 negative 
decontaminated tissue samples.  The DNA was amplified in a PCR mix without Q 
solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    1       2              4              6             8            10              12             14            
 
Figure 4.34: Gel showing products of sequence capture PCR, amplified without Q 
solution.  Lane 1 50bp ladder, Lane 2-9 & 12-13 decontaminated tissue samples, Lane 
10-11 PBS blank and Lane 14-15 MTBC culture. 
  
SQCap no Q MTBC Neg 
High (7) 5 2 
Medium (9) 7 2 
Low (11) 7 4 
Total (27)  19 8 
Negative (3)  3 
MTBC  
Culture 
PBS 
Blank Tissue 
1 
Tissue 
2 
Tissue 
3 
Tissue  
4 
Tissue  
5 
270bp 
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       1          2                   4                  6                  8                  10                 12      13  
 
Figure 4.35: Gel showing products of sequence capture PCR of a serial dilution of M. 
bovis spiked into negative decontaminated tissue.  Lane 1 & 13 50bp ladder, Lane 2-
11 serial dilution of M. bovis, 1x10
-1 – 1x10-5 and Lane 12 PCR water control.  
 
 
 
       1        2                    4                   6                  8                 10                 12          13 
 
Figure 4.36: Gel showing products of sequence capture PCR of a serial dilution of M. 
bovis spiked into negative decontaminated tissue.  Lane 1 & 13 50bp ladder, Lane 2-9 
serial dilution of M. bovis, 1x10
-6– 1x10-9, Lane 10-11 PBS spiked negative tissue and 
lane 12 PCR blank control. 
 
 
      1         2                 4                   6                   8                  10                 12 
 
Figure 4.37: Gel showing products of sequence capture PCR of a serial dilution of M. 
bovis spiked into negative decontaminated tissue.  Lane 1 & 12 50bp ladder, Lane 2-3 
MTBC culture, Lane 4-5 neat M. bovis stock, Lane 6-7 PBS blank Lane 8-9 M. bovis 
DNA, Lane 10-11 M. bovis PCR positive control. 
 
MTBC 
Culture 
Neat 
M. bovis 
Stock 
PBS 
Blank M. bovis 
DNA 
M. bovis 
PCR Cntl 
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 Tissue 
PCR 
Blank 
Cntl 
M. bovis 
in tissue 
1 x 10
-1 
M. bovis 
In tissue 
1 x 10
-2 
M. bovis 
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-3 
PCR 
Water 
Cntl 
270bp 
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sensitive than the culture result of 2.5 x 10
2 
cfu/ml, shown in section 3.2.  All the 
controls gave the expected results. 
Sequence Capture PCR is extremely sensitive and could potentially detect a 
MTBC infection that was missed by culture.  The increase sensitivity may be due to 
the fact that culture can only detect the viable M. bovis cells remaining in the tissue 
following storage of the sample at -20
o
C prior to culture and decontamination.  
Sequence capture may be able to pull M. bovis DNA from cells that are no longer 
viable but still remain in the tissue. 
 
4.3 Discussion 
The purpose of this study was to evaluate several different methods for the 
extraction of mycobacterial DNA from decontaminated LN tissue for use with high 
priority samples.  Each of the five methods used, heat lysis, Roche High Pure 
Template Preparation kit, Immunomagnetic Separation (IMS), GenoType 
Mycobacteria Direct kit and Sequence Capture PCR, had previously been employed 
to extract mycobacterial DNA from a wide variety of sample types including milk, 
sputum, tissues and mycobacterial culture isolates. 
Heat Lysis was included in this study, since it was a simple and effective 
technique for releasing DNA from a sample.  It had no DNA purification capability 
and was shown not to be sensitive or specific enough to extract mycobacterial DNA 
from decontaminated LN tissue, section 4.2.1.   The Roche High Pure Template 
Preparation kit isolated the total nucleic acids, separating them from other 
contaminating molecules, within the sample using absorption chromatography.  Due 
to the sample type, lymph node tissue, nucleic acids from the tissue itself and any 
contaminating bacteria would be purified along with nucleic acids from any 
mycobacterial cells present.  This meant that the technique was not specific enough to 
extract mycobacterial DNA from decontaminated LN tissue, section 4.2.2. 
IMS was included in this study since it was a technique designed to extract a 
target cell type from a heterogeneous cell suspension.  An advantage of IMS, over the 
other methods evaluated, was that it could provide information on the viability of any 
mycobacteria within the tissue and could also be adapted for use as an enrichment 
step prior to culture.  IMS had been used in the isolation of mycobacterial cells from a 
wide variety of sample types (milk, faeces and cerebrospinal fluid), including M. 
bovis from milk (Li et al., 1996; Mazurek et al., 1996; Grant et al., 1998; Antognoli et 
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al., 2001; Djønne et al., 2003; Khare et al., 2004).  Fu et al., had shown the suitability 
of IMS for the isolation of E. coli 0157:H7 cells from ground beef for direct detection 
with a real-time PCR method (Fu et al., 2005).  The matrix used in that study, ground 
beef, differs from LN tissue but would have a greater similarity to it than milk, faeces 
or cerebrospinal fluid.   
IMS was not sensitive enough to detect the low numbers of MTBC cells found 
in the decontaminated samples, section 4.2.3.  A pre-treatment step was required to 
breakdown the tissue before the MTBC cells could be isolated.  The technique relies 
on the specificity of antibodies, bound to magnetic beads, to isolate the target cells 
meaning a chemical or enzymatic pre-treatment step could not be used, since it would 
be impossible to ensure than all molecules of the chemical or enzyme used in the pre-
treatment were removed from the sample prior to addition of the antibody bound 
beads.  This could lead to a source of false negative results for IMS.  This limited the 
pre-treatment to physical disruption, bead-beating was select, and this was shown not 
to be successful.  Increasing the length of time to antibody bound beads were allowed 
to interact with the sample also failed to improve the results.  Fu et al., 2005 
suggested that reducing the size of the magnetic bead used to bind to the antibodies, 
might improve cell capture, however this was ineffective. 
When a serial dilution of M. bovis, spiked into both PBS and negative LN 
tissue, was extracted using IMS, the technique was shown to have a similar sensitivity 
to that of culture, 2.3 x 10
2 
cfu/ml, when used with PBS but the sensitivity dropped by 
a factor of 10, 2.3x 10
3 
cfu/ml, when used with LN tissue.  This figure is similar to the 
lowest detection limit of IMS when used on E. coli 0157:H7 cells in ground beef of 
1.6 x 10
3 
cells/ml (Fu et al., 2005).   
The primer, MSP 1/2, used to amplify the extraction products from heat lysis, 
Roche High Pure Template Preparation kit and IMS was specific to mycobacteria not 
MTBC cells (Roth et al., 2000).  If any mycobacterial DNA had been detected by 
PCR in the decontaminated tissue cells further testing would have been required to 
confirm the presence of MTBC DNA.  This primer was selected since it would allow 
the detection of non-tuberculosis mycobacteria (NTM) from the decontaminated 
tissues.  These mycobacteria are not critical to the bovine eradication scheme but they 
can provide information to improve animal health and husbandry. 
The GenoType Mycobacteria Direct kit was shown in this study, after the 
addition of an overnight Proteinase K digestion, to be able to correctly identify 63.3% 
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(19 out of 30) of the decontaminated tissue samples, section 4.2.4.  The previously 
published evaluations of this kit for the direct detection of mycobacteria from clinical 
samples are based primarily on respiratory samples, with only a small number of 
extra-pulmonary samples tested, and none of which include a pre-treatment step 
report a sensitivity for mycobacteria of approximately 90%, depending on the report 
(Kiraz et al., 2010; Neonakis et al., 2009; Seagar et al., 2008; Franco-Álvarez de 
Luna et al., 2006; Fakrin et al., 2007).   
This difference may be due to the pre-treatment with Proteinase K but this is 
unlikely.  The more probable reason is the nature of the sample type evaluated with 
LN tissue potentially containing more PCR inhibitors than respiratory sample.  Work 
carried out by Ben Kahla et al. comparing the sensitivity of a IS6110 PCR for direct 
detection of M. tuberculosis in pulmonary samples (sputum, bronchial wash and 
gastric lavage) and extra-pulmonary samples (pleural fluid, cerebrospinal fluid, tissue 
biopsy, urine, sperm, peritoneal fluid and joint fluid) noted a drop in sensitivity of the 
PCR from 93.8% for pulmonary samples to 63.6% for extra-pulmonary samples 
which was put down to the presence of PCR inhibitors or loss of M. tuberculosis cells 
during the DNA extraction process (Ben Kahla et al., 2011). 
The remainder of the 30 decontaminated tissues samples were split into false 
negative results, 16.7% (5 out of 30), and test failures, 20% (6 out of 30).  The false 
negative results were probably due to the low number of MTBC cells in the 
decontaminated tissue, reduced even further by the pre-dilution of some of the 
samples, and the test failure, indicated by the absence of a UC (universal control) 
band on the strip, were due lack of amplification the internal control RNA during the 
NASBA reaction which was probably caused by the presence of PCR inhibitors 
within the tissues.  It is possible that the addition of extra washing steps to the 
decontaminated tissue pellets, with PBS or saline, may help remove any PCR 
inhibitors present in the tissue, as done by Ben Kahla et al., however this may cause 
the loss of some MTBC cells within the tissue leading to a false negative result (Ben 
Kahla et al., 2011).  It should be noted that 2 of the 3 culture negative decontaminated 
tissue samples failed when tested with the kit after addition of the Proteinase K 
digestion, so it was not possible to draw a conclusion from the lack of false positive 
results. 
Using a serial dilution of M. bovis spiked into negative LN tissue and pre-
treated with the Proteinase K the limits of detection for the kit were shown to be 2.3 x 
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10
2 
cfu/ml, Figure 4.32, which is similar to the limits of detection of M. bovis for 
liquid culture shown in section 1.2.l.  This indicates the potential of the kit for use 
with high priority samples but at the current time, due to the false negative results and 
the lack of conclusive information about false positive results in this study, it could 
only be used as an information tool within the laboratory and not as a basis of 
reporting the TB infection status of an animal. The ability of kit to detect more 
mycobacterial species than MTBC, including M. avium, M. intracellulare, M. 
malmonense and M. kansasii, which have all previously been detected during TB 
culture in the CVRL (unpublished data), is also a advantage for future use of this kit.   
A major obstacle against the future use of this kit was the failure of the 
supplied positive control to give a clear banding pattern and no reason can be found 
for this error.  Two different kit lot numbers were used during this project, all reagents 
were prepared correctly and used in date and all equipment, except pipettes and 
plastic tubes, used in the amplification and detection steps were supplied by the 
manufacturer.  Further work also needs to be carried out to determine if the number of 
test failures and false negative results can be reduced and to determine if any false 
positive results are detected with this kit.  The tissue samples that had been pre-
diluted before being tested on the kit could not be repeated due to the lack of sample 
material.  
Sequence Capture PCR was a known method for the direct detection of MTBC 
cells from decontaminated LN tissue.  It was included in this study to prove that 
mycobacterial DNA could be recovered from the 30 decontaminated tissues used.  
The method correctly identified the infection status of 73.3% of the decontaminated 
tissues, this was lower than the sensitivity seen in Roring et al., which has 97% when 
a sequence capture extraction method was coupled with spoligotyping to detect M. 
bovis in LN tissues, but similar to that seen in other studies, Parra et al. average 
sensitivity of 73.87%, and Mangiapan et al. sensitivity of 76.5%, for the detection of 
MTBC from tissues (Roring et al., 2000; Mangiapan et al., 1996; Parra et al., 2008).  
This was probably due to the low number of MTBC cells in some decontaminated 
tissues, which was not helped by the pre-dilution step for some samples.  
Unfortunately, there was not enough material remaining to re-test all 30 samples 
without the pre-dilution step to determine if this would improve the sensitivity of the 
technique.  As with the GTMD kit, the level of false negative results identified in this 
study means this test could be used to provide information on the TB infection status 
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of high priority samples, such as Singleton Reactor animals or pets, for the laboratory 
use only and not as a definitive diagnostic tool.   
A limit of detection study was carried out with M. bovis spiked into negative 
LN tissue and this showed that sequence capture PCR was able to detect M. bovis 
down to a concentration of 2.3 x 10
1 
cfu/ml, Figure 4.35 to 4.37.  This indicated that it 
could detect lower concentrations of M. bovis than liquid culture systems that had a 
limit of detection of 2.5 x 10
2 
cfu/ml.  This points to the value of the technique since it 
could be used to detect bovine TB in tissues which have too few MTBC cells or cells 
that are not viable for culture.   
 
4.4 Conclusion 
The MTBC direct detection methods evaluated in this study have been used to 
extract mycobacterial DNA from a wide variety of sample types.  Heat lysis, a simple 
and effective method for extraction of DNA from pure cultures is not sensitive or 
specific enough for use with lymph node tissue.  The Roche High Pure Template 
Preparation Kit removes the total DNA from a given sample, but it does not have the 
ability to select mycobacterial DNA from any other contaminating DNA within the 
sample.   
The use of IMS to remove the MTBC cells from the decontaminated tissues 
prior to DNA extraction was unsuccessful.  The method was not sensitive enough to 
remove the low number of MTBC cells, typically found in TB infected tissues, from 
the tissue sample.  
The GTMD Kit Version 4.0, with the addition of the Proteinase K incubation 
overnight, was able to detect MTBC cells in the decontaminated tissue samples and 
had a similar sensitivity to that of culture.  The GTMD kit can be started immediately 
after culture and completed the following day.  It can be easily integrated into the TB 
laboratory workflow, since the MB extraction and NASBA reaction can be carried out 
within the Category 3 Laboratory.  With bio-security concerns, removal of an 
amplified product is preferable to removal of potentially viable MTBC cells.  The 
continued failure of the positive control supplied with the kit is an issue, but a MTBC 
positive solid culture was always correctly identified. 
The sequence capture PCR was shown by this study to be a very effective and 
rapid method for the diagnosis of an M. bovis infection in lymph node tissues.  A 
result could be available for preliminary reporting 3 days after culture.  Similar to the 
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GTMD kit, the enzymatic digestion of the decontaminated tissues can be started soon 
after completion of the culture procedure.  The remainder of the extraction procedure, 
mechanical disruption and binding of the released DNA to the capture 
oligonucleotides and MB, could be carried out the following day.  Amplification of 
the extracted DNA could be carried out overnight and detected, on a gel, on day 3 
after culture.  Modifications to the amplification and detection procedure for use with 
Real-Time PCR would speed up this part of the test.  
The MTBC positive tissues, 27 in total, were classed as high, medium to low 
positives based on a direct ZN examination of the decontaminated tissue homogenate 
prior to inoculation into the culture media, as per section 2.11.  This was done on the 
theory that samples that had a high MTBC load may be more likely to be identified by 
direct detection methods.  This was found not to be the case, for the GTMD kit the 
percentage number of positive decontaminated LN tissue samples correctly identified 
was, 57.1% of high positives, 77.8% of medium positive and 63.7% of low positives.  
For Sequence Capture PCR, without Q solution in the PCR mix, the percentage of the 
number of samples correctly identified was 71.4% of high positives, 77.8% of 
medium positive and 63.6% of low positives. 
For this study, following enzymatic and mechanical disruption, the samples 
for sequence capture PCR were removed from the Category 3 Laboratory due to lack 
of the necessary equipment for the capture oligonucleotides and MB binding steps.  
With modifications to the allocation of resources both these steps could be carried out 
in the Category 3 Laboratory with only the amplification and detection work needing 
to be carried outside of the TB laboratory.   
This study has found that both the GTMD kit and sequence capture PCR are 
suitable for use in detection of MTBC cells from decontaminated lymph node tissue 
with sequence capture PCR having an increased sensitivity over the GTMD kit but 
both need further work to determine if the sensitivity can be improved.  The choice 
between both methods would probably be made on a cost per test basis and the ease of 
adaption of either method into the existing TB workflow.  Ease of integration of any 
direct detection method into the existing TB workflow is important since the 
turnaround time for samples must be maintained and only a limited number of staff 
have the necessary training for working with mycobacteria.  
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Chapter 5. 
 
 
General Discussion. 
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This study was concerned with the detection of MTBC, specifically M. bovis, 
from LN tissue.  The project looked at the possibility of developing improved MTBC 
culture methods and molecular methods for the direct detection of MTBC from 
decontaminated LN tissue. 
 As part of this study a comparison was carried out between two liquid culture 
systems to determine if MGIT 960 system would be a suitable replacement for the 
BACTEC 460 system.  Previously published work had shown that the MGIT 960 
compared favourably to the BACTEC 460 and solid culture systems for the culture of 
MTBC from human clinical samples but was of only limited use for MTBC culture 
from bovine tissue samples (Chew et al., 1998; Scarparo et al., 2002; Kanchana et al., 
2000; Hanna et al., 1999; Somoskövi et al., 2000; Tortoli et al 1999; Zuhre Badak et 
al., 1996; Yearsley et al., 2000).  The manufacturer altered the media formulation to 
improve this and a study published in 2006 showed that the MGIT 960 system was 
capable of supporting M. bovis growth however it showed a much lower detection rate 
for M. bovis in the BACTEC 460 system (Hines et al., 2006).  
For the culture of MTBC from lymph node tissue the BACTEC 460 is a well-
established culture system that has evolved to become the “gold-standard” by which 
other culture systems are measured (Zuhre Badak et al., 1996).  It is a semi-automated 
liquid culture system that detects growth by the release of radioactive CO2 from the 
use of C
14
 labelled palmitic acid by bacteria in the culture media (Yearsley et al., 
1998).  MGIT 960 is a fully automated, continuous monitoring, high capacity, non-
radiometric, non-invasive instrument (Kanchana et al., 2000).  It uses an O2 
quenching fluorescent sensor, imbedded at the base of the tube, to detect microbial 
growth with the culture vials (Scarparo et al., 2002). 
The results from the limit of detection study, shown in section 3.2.1, showed 
that MGIT 960 liquid culture system was now capable of supporting the growth of 
MTBC, specifically M. bovis, and had a similar limit of detection for M. bovis to that 
of the BACTEC 460 liquid culture system.   
In the comparison between the two liquid culture systems, each combined with 
solid culture systems (LJP and Stonebrinks), section 3.2.2, MGIT 960 detected 97.7% 
of the MTBC infected tissues compared to BACTEC 460 detecting 96.6% of the 
MTBC infected tissues, using routine lymph node tissue samples.  The MGIT 960 
detected the growth of MTBC approximately slight faster than the BACTEC 460 
(14.6 days for MGIT 960 and 15.2 days for BACTEC 460). 
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Due to the limited number of non-tuberculosis mycobacteria (NTM) isolated 
during this study it is difficult to draw firm conclusions.  From the limited data 
available it would seem that the MGIT 960 system does not support as many NTM 
isolates as the BACTEC 460 system.  Further work would need to be undertaken to 
determine which NTM the MGIT 960 system can support and if alterations to the 
culture conditions or the solid culture systems utilized could improve the number of 
NTM isolates identified from LN tissue.  
The MGIT 960 liquid culture system does have added labour requirement for 
reprocessing of contaminated sample tubes, with contamination rate of 8.2% for 
MGIT 960 compared to a rate of 3.1% for BACTEC 460.  Also the increased isolation 
of R. equi with the MGIT 960 system, 96.6% with MGIT 960 compared to 78.4% 
with BACTEC 460, will increase the number of samples that require handling.  This 
would be offset by the reduced number of atypical mycobacteria detected by the 
MGIT 960 liquid culture system and the automated monitoring of culture in the 
MGIT 960 instrument is an automated system and once the MGIT tubes are entered 
into the MGIT 960 instrument (see Figure 1.9) they are continuously monitored.  The 
MGIT tubes are read every 60 min and a LED indicates which tubes have flagged as 
positive.   
The MGIT 960 culture monitoring has a much reduced labour requirement 
compared to the BACTEC 460 system.  The BACTEC 460 media bottles need to be 
removed from the 37
o
C incubator, loaded onto sample boats, monitored by the 
BACTEC 460 instrument, unloaded and returned to the incubator.  The BACTEC 460 
instrument converts any detected radioactive CO2 into a Growth Index (GI) number 
and this is printed on a strip of paper along with the sample boat and position.  This 
information then has to be transcribed to the sample number in that sample boat 
position adding a risk of handling errors to the process.  There is no computerised data 
handling system compatible with the BACTEC 460 instrument.  Even with the 
increased numbers of samples that will require handling due to contamination or 
growth of R. equi, the MGIT 960 liquid culture system has an overall reduced labour 
requirement when compared to the BACTEC 460. 
When safety concerns are looked at the MGIT 960 system is a non-radiometric 
and non-invasive culture system and is much safer to operate than the BACTEC 460 
system.  This is due to the necessity of handling, storage and disposal of radioactive 
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material, C
14
, and the potential of needle stick injuries during vial inoculation and 
sampling procedures with the BACTEC 460.  
The manual supplied by the manufacturer stated that CPC decontamination 
was not suitable for use with the MGIT 960 liquid culture system (Siddiqi and Rüsch-
Gerdes, 2006).  CPC decontamination of tissues was used as part of a long-running 
badger project within the CVRL, which included MTBC culture on BACTEC 460 
liquid culture system a part of the protocol. Confirmation was required as to how 
unsuitable this method was for culture of MTBC from lymph node tissue.  Bovine LN 
tissues were used instead of badger LN tissue due to a more readily available source.   
It was shown, section 3.2.3, that CPC decontamination reduced the isolation of 
MTBC on MGIT media tubes, from 89.5% with OA to 5.3% with CPC, and on solid 
culture systems, from 63.2% with OA to 47.4% with CPC.  The contamination rate 
between the two culture methods also indicated that CPC was not suitable for 
decontamination of LN tissue for MTBC culture, in MGIT media CPC contamination 
rate was much lower, at 1.32%, than OA, at 4.86%.  The contamination rate for solid 
culture systems, with CPC decontamination, was much higher, at 18.75%, than for 
OA decontamination, at 10.42%.  A surprising result was how much more R. equi was 
isolated, when grown on solid culture systems, with CPC decontamination, 100%, 
than with OA decontamination, 72.7%.  If further studies take place on R. equi 
isolation the use of CPC decontamination, with solid culture systems only, should be 
considered. 
This study has shown that the MGIT 960 liquid culture system can support the 
growth of MTBC, specifically M. bovis and is a suitable replacement for the 
BACTEC 460 system.  It agrees with the findings of the work on human clinical 
samples in that both liquid culture systems give similar MTBC detection rates unlike 
the Hines et al. study which showed a much lower M. bovis detection rate with the 
BACTEC 460 system compared to the MGIT 960 system (Chew et al., 1998; 
Scarparo et al., 2002; Kanchana et al., 2000; Hanna et al., 1999; Somoskövi et al., 
2000; Tortoli et al 1999; Zuhre Badak et al., 1996; Hines et al., 2006).    The 
difference can‟t really be explained by the addition of erythromycin to the BACTEC 
460 bottle in the Hines et al. report so it is unknown at this time what it could be the 
cause of this differing result. 
It would not be possible, on a safety and cost basis, to continue limited use of 
the BACTEC 460 system for a project and the MGIT 960 system has been shown to 
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be unsuitable for use with CPC decontamination.  The Badger Vaccine Project, 
described in brief in section 3.1, could increase the number of solid culture systems 
(LJP, Stonebrinks and 7H11 plates) included in the culture protocol to compensate for 
the removal of the BACTEC 460 system and the unsuitability of MGIT 960 system 
for use with CPC decontamination protocol used in the project.  The CPC 
decontamination protocol is used with the Badger Vaccine Project since it allows for 
the alterations to the concentration of decontaminant, depending on the source and 
condition of the tissue samples for culture, potentially increasing the number of 
MTBC isolates detected (Corner et al., 1995). 
A method to diagnose a MTBC infection directly from LN tissue would be a 
useful technique to have available in cases were a rapid diagnosis of MTBC infection 
is required.  These would include samples where there is a suspected human 
involvement i.e. family pet or where unpasteurised milk or milk products had been 
consumed from an animal with a suspect TB infection, and samples submitted from 
Singleton Reactor animals.  The five methods evaluated for the extraction and 
detection of MTBC cells, Heat Lysis, Roche High Pure PCR Template Preparation 
Kit, Immunomagnetic Separation (IMS), GenoType Mycobacteria Direct kit (GTMD) 
and Sequence Capture, shown in Chapter 4, were all used to extract or detect 
mycobacteria from a wide variety of samples.  Sequence Capture PCR was the only 
method that had already been shown to detect M. bovis in decontaminated LN tissue 
(Roring et al., 2000; Mangiapan et al., 1996; Parra et al., 2008).   
Heat Lysis was a simple and effective method for releasing DNA from cells 
but it was shown, section 4.2, not to be sensitive or specific enough for use with 
decontaminated LN tissue.  Roche High Pure PCR Template Preparation Kit isolated 
the total DNA from the decontaminated sample, but it does not have the ability to 
select mycobacterial DNA from any other contaminating DNA. 
IMS was selected for evaluation since along with being used to diagnose a 
MTBC infection; it could also provide information on the viability of the infection.  
IMS had already been used to detect mycobacterial infections, including M. bovis, in a 
wide variety of samples such as milk, faecal samples and cerebrospinal fluid (Grant et 
al., 1998; Djønne et al., 2003; Khare et al., 2004; Li et al., 1996; Mazurek et al., 
1996; Antognoli et al., 2001).  In this study IMS was shown not to be powerful 
enough to concentrate MTBC cells from decontaminated LN tissue, section 4.2.3.  
This may have been due to a wide variety of reasons including the low number of 
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MTBC cells typically found in decontaminated tissue samples and the presence of 
molecules, such as immunoglobulins and proteases that may interfere the antibody-
antigen binding reaction.   
GTMD had already been shown to detect MTBC infection in a wide variety of 
samples but it has yet to be shown suitable for detection of a M. bovis infection in LN 
tissue (Seagar et al., 2008; Franco-Álvarez de Luna et al., 2006; Fakrin et al., 2007; 
Kiraz et al., 2010; Neonakis et al., 2009).  The advantage of this kit is that it can be 
used to diagnose some NTM infections along with the MTBC.  In section 4.2.4, after 
the addition of an overnight enzyme digestion, the GTMD had a sensitivity for M. 
bovis similar to that of culture, at 2.3 x 10
2
cfu/ml, when spiked into culture negative 
decontaminated LN tissue.  However, when tested on routine culture decontaminated 
tissue samples it only correctly identified 63.3% of the MTBC positive samples.  
There were no false positive results detected with this kit but this is not a definitive 
conclusion due to the small sample size, 3 samples, of MTBC culture negative tissues 
included in the study and the test failure of 2 of the 3 samples. 
As stated previously, Sequence Capture PCR was the only method evaluated 
that had already been shown to detect M. bovis in decontaminated LN tissue.  In this 
study, section 4.2.5, it was shown to have sensitivity, for M. bovis, 10 times greater 
than culture, at 2.3 x 10
1
cfu/ml, when spiked into decontaminated LN tissue while 
only correctly identifying 73.3% of the decontaminated tissue samples.  A similar 
sensitivity level for detection of MTBC isolates directly from bovine LN tissues had 
been reported previously (Mangiapan et al., 1996; Parra et al., 2008) 
The choice between GTMD or sequence capture for direct detection of an 
MTBC infection in LN tissue would depend on a number of factors including cost, 
ease of use within the current TB workflow, requirement of the downstream processes 
and increasing the sensitivity of both techniques when compared to culture.  The 
product of sequence capture PCR can be adapted for a wide variety of molecular tests 
while the GTMD can diagnose several mycobacterial infections within a single test. 
  Further evaluations need to be carried out to determine if the sensitivity of 
either of these tests could be improved, perhaps by removing the pre-dilution step for 
the decontaminated tissue samples included in this study.  It may be that increased 
familiarity within either test might also improve the sensitivity results.  This work was 
carried out on only 30 decontaminated tissue samples and comparing both tests on a 
wider sample pool may indicate which test would be more suitable for use on 
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veterinary samples.  Both tests remove MTBC DNA from LN tissue material and the 
possibility of coupling either to another extraction procedure to determine if the 
sensitivity can be improved would be remote, though perhaps increasing the number 
of washing steps, as suggested in Ben Kahla et al., could be considered (Ben Kahla et 
al., 2011).  For sequence capture PCR the option exists of varying the capture 
oligonucleotides to target a different section of the M. bovis genome, this may 
increase the sensitivity of the technique. 
In conclusion, this study has shown that MGIT 960 system is a suitable liquid 
culture system to replace the use of the BACTEC 460 system for the culture of 
MTBC from LN tissues.  It was also shown that the MGIT 960 liquid culture system 
is not suitable for use with CPC decontamination.  For the extraction and detection of 
MTBC cells from decontaminated LN tissue the GTMD kit and Sequence Capture 
PCR are both potential methods and the choice between either techniques is based on 
cost, ease of adaptation to the current TB workflow within the Central Veterinary 
Research Laboratory (CVRL) and improved the sensitivity for MTBC.  It is unlikely 
that either direct detection test will replace culture for the diagnosis of MTBC 
infection in the near future, though sequence capture PCR coupled with a real-time 
PCR has been proposed as a screening tool for M. bovis as part of the bovine 
tuberculosis abattoir surveillance program (Parra et al., 2008) 
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